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The purpose of this thesis is to implement all the translation skills acquired during the 
study of English Language and Literature. The most appropriate technique to master the 
translation skills is by translating the texts of various genres as it is done in this thesis. 
Moreover, the focus is put on overcoming all the various obstacles that we encounter while 
translating. 
The thesis is divided into five main sections. The first section of the thesis is the introduction 
part and it includes the main principles of the translation process. What is more, this part 
contains brief reviews of the source texts. The following sections include the source text, 
corresponding translation as well as the commentary and analysis. In the commentary and 
analysis the recipient of the translation gets the insight into the translation process, which 
includes the analysis of the text based on the twelve main points (genre, source, audience, 
purpose of writing, authenticity, style, level of formality, layout, content, cohesion, sentence 
patterns and terminology of the subject) and particular observations on various issues 
encountered while translating. The last section of this thesis is the conclusion and its purpose 
is to summarise the most relevant conclusions regarding the translation of the texts of various 
genres.  
The source language of the texts is English, while the target language is Croatian. The source 
texts include three different genres: research in the field of medicine, overview of the health 
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Translation is a process that can be defined with multiple definitions, and different authors 
provide their own explanation of the term. One of the simplest clarification of this expression 
is that „translation is transferring the meaning of the source language into the receptor 
language“ (Larson, 1984:3). In other words, translation is a process in which the translator 
repeats the author´s words and ideas in different language. The aim of this thesis closely 
relates to this definition. By translating three texts of different genres, the significance was put 
onto transferring the authors´ ideas into Croatian language without altering the meaning of the 
main ideas, basic facts, style and structure.  
In order to fully understand what translation really is, it is important to explain the role of the 
translators and what is expected of them. Due to the fact that language is like a living 
organism and it is changing on a daily basis, the role of the translator can be quite demanding. 
Every language is unique, having its own specific metaphors, expressions, phrases and 
idioms, so translating from the source language to the target language can be quite a 
challenging task. That is why the translator needs to be an expert regarding the source 
language, but even more proficient when it comes to the target language. Furthermore, the 
translator can stumble upon various obstacles while translating. When it comes to the 
vocabulary usage, various terms have multiple meanings and the translator needs to focus on 
the surrounding text while translating in order to keep the original meaning of the word and 
the sentence. Besides that, translator has to be careful when it comes to style and tone of 
translation because these elements should correspond to the source language. Translator needs 
to pay attention to the formality level of the text as well. If there is a high level of formality, 
translator needs to avoid colloquial expressions. What is more, translator needs to bear in 
mind that the translation needs to correspond to the original text, taking into consideration the 
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context of a text, the culture of the source language and the recipients of translation. These are 
just some of the elements which need to be taken into account while translating.  
When dealing with few texts of the same genre, some of these elements can be easily omitted 
and that is why the main focus in this thesis is put on three texts of different genres and 
contexts. Prior to the beginning of the translation process, every text needs to be read and 
analysed in the interest of getting a complete overview of the topic. Due to the fact that these 
three texts belong to different fields of matter, before the translation of every text, it is 
necessary to read several Croatian articles on similar topics in order to get acquainted with the 
terminology and the style of writing. After thorough analysis of the genre, terminology, style 
and structure, the translation process can start. 
The first source text “Perspectives on reasons of medication nonadherence in psychiatric 
patients“ is a research analysis and it belongs to the field of medicine. Due to the high level of 
formality the translator´s role is to translate the text trying to convey the meaning of the 
original work by translating the official terminology of the source language into the 
corresponding terms of the target language. Medical terminology has a vast range of complex 
expressions and that is why the translator needs to use medical dictionaries or even consult an 
expert of that field.  
The second source text “Overview of the U.S. Health Care System“ belongs to the field of 
health care and the level of formality is not that high as in the first text due to the fact that it is 
a summarised overview of the United States’ health services written for general population. 
The translation of this text can be considered complex because the translator needs to bear in 
mind that the original text is written for the population that has a different culture than the 
target language. Besides that, the translator needs to transfer the original names of 
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programmes into the target language which can be quite challenging because some of these 
terms do not exist in the target language.  
The third text “Being the first man on the Moon“ is an interview with Neil Armstrong and it is 
mostly focused on the space exploration and Armstrong´s life. This text is quite informal due 
to the great number of colloquial expressions.  
Translation of every text is followed by the commentary and analysis. In this part, translator 
analyses the texts according to the previously selected points such as genre, source, style, 
content, etc. Besides that, translator explains the process of translating, guiding the recipient 
of the translation through different steps of transferring the meaning of the source language 
into the target language. In this part of the thesis, translator specifies the issues of the 
translation process, provides a thorough explanation of several translated terms and in some 
cases brings up a list of examples found in various text and articles.  
In the conclusion, translator reflects on the overall course of translating. 
While translating, the translator needs to focus on all the elements mentioned in the first part 
of the introduction. The translator is not just a person who transfers the meaning of source 
language into the target language. The translator is basically an author and a creator because 
the aim of translating is to create something new. Even though the essence of the translated 
text needs to correspond to the original text, the translator has to improvise and conduct a 
thorough exploration in order to make the translation valid. As Roger Chriss (2006) stated, 
translators are “language professionals. They are applied linguists, competent writers, 





2. SOURCE TEXT I:  
Perspectives on reasons of medication nonadherence in psychiatric 
patients 
Derya Güliz Mert 
Nergiz Hacer Turgut 
Meral Kelleci 
Murat Semiz 
Purpose: This study was carried out to evaluate factors resulting in medication nonadherence 
within 6 months before admission to the psychiatric service of our hospital for bipolar 
disorder, schizophrenia/schizoaffective disorder, depression, and other psychiatric diseases. 
Patients and methods: Two hundred and three patients admitted to the Psychiatry Service of 
the Medical Faculty were included in this study. Sociodemographic parameters and clinical 
findings within 6 months before admission and patients’ views on reasons of medication 
nonadherence were examined. 
Results: Patients were classified into four groups according to their diagnosis: bipolar 
disorder (n=68, 33.5%), schizophrenia/schizoaffective disorder (n=59, 29.1%), depression 
(n=39, 19.2%), and others (n=37, 18.2%). The ratio of medication nonadherence was higher 
in the bipolar disorder group when compared to the groups with schizophrenia/schizoaffective 
disorder, depression, and other disorders (12.1%, 18.2%, and 24.2% vs 45.5%); however, the 
ratio of medication nonadherence was similar in schizophrenia/schizoaffective disorder, 
depression, and the others group. In logistic regression analysis, irregular follow-up (odds 
ratio [OR]: 5.7; 95% confidence interval [CI]: 2.92–11.31) and diagnosis (OR: 1.5; 95% CI: 
1.07–1.95) were determined to be important risk factors for medication nonadherence. The 
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leading factors for medication nonadherence were: “not willing to use medication”, “not 
accepting the disease”, and “being disturbed by side effects” in the bipolar disorder group, 
“not accepting the disease” in the schizophrenia/schizoaffective disorder group, “feeling well” 
in the depression group, and “being disturbed by side effects” in the other diseases group. 
Conclusion: Medication nonadherence is an important problem in psychiatric patients and 
should be dealt with by taking into account the diagnosis, attendance to follow-up 
appointments, and the patient’s attitude. Ensuring regular attendance to follow-up 
appointments, adjusting the management plan according to the diagnosis, and improving their 
thoughts about resistance to medication can be beneficial in terms of medication adherence. 
Keywords: bipolar disorder, schizophrenia, schizoaffective disorder, depression, patient’s 
attitude 
Introduction 
The World Health Organization has reported the ratio of medication adherence as around 50% 
in people with a chronic disease. Nonadherence to treatment is a major problem in psychiatric 
patients; a recent review has stated a ratio of 20%–60% in psychiatric patients. Treatment 
nonadherence can be in the form of not taking the medication at the recommended dose and 
frequency, not taking the medication at all, and irregular attendance to follow-up 
appointments or not attending at all. The most important and highly encountered form of 
medication nonadherence is where a patient does not follow the recommended dose and 
frequency. The ratio of nonadherence has been reported as 40%–60% for antipsychotics, 
18%–56% for mood stabilizers, and 30%–97% (63% on average) for antidepressants. 
Moreover, in studies evaluating medication adherence based on diagnosis, the ratio of 
nonadherence to medication has been shown to be 12%–64% in patients with bipolar 
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disorders, 11%–80% in patients with schizophrenia, and 30%–60% in patients with 
depression.  
There are many factors leading to medication nonadherence in psychiatric patients, 
including lack of insight into having an illness, distress associated with side effects, disturbing 
side effects affecting quality of life, lack of family and social support, insufficient information 
on the disease and treatment, and substance abuse or addiction. The Diagnostic and Statistical 
Manual of Mental Disorders (DSM)-V describes many conditions for medication 
nonadherence, including overweight or obesity, malingering, wandering associated with a 
mental disorder, and borderline intellectual functioning. Medication nonadherence is one of 
the major avoidable reasons causing relapses and morbidity. For this reason, reasons of 
nonadherence should be examined while evaluating patients. History of nonadherence, 
alcohol or substance use during symptom-free periods, medication doses, multiple medication 
use, side effects, and therapeutic alliance should be investigated in detail. As medication 
nonadherence frequently causes exacerbations, relapses, harmful behavior to oneself or one’s 
environment, suicide and rehospitalization, it has negative impacts both on patients and their 
family and society. Hospitalization can be associated with medication nonadherence in 20% –
25% of psychiatric patients.  
Studies on medication nonadherence, which has an important role in the treatment of 
psychiatric diseases, and factors associated with nonadherence usually address a single 
diagnosis group. In the literature, there are an insufficient number of studies comparing 
different diagnosis groups in terms of medication nonadherence. Moreover, studies assessing 
the contribution of patients’ features and disease-related factors to medical nonadherence are 
not sufficient either. Results to be obtained on reason of medication nonadherence may have a 
great impact on inpatients’ treatment and outpatient follow-ups. In the present study, factors 
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resulting in medication nonadherence within 6 months before admission to the psychiatric 
service of our hospital for bipolar disorder, schizophrenia/schizoaffective disorder, 
depression, and other psychiatric disorders were evaluated from a multidimensional approach. 
Patients and methods 
Study population 
The present cross-sectional study was conducted on patients hospitalized at the psychiatry 
clinic at our hospital for bipolar disorder, schizophrenia and schizoaffective disorders, 
depression, and other psychiatric disorders. Before the study was conducted, the approval of 
the Human Research Ethics Committee was obtained. All patients receiving treatment 
between October 2013 and February 2014 were asked to participate in the study, and those 
willing to participate were included in the study upon receiving consent. The term covering 6 
months before the study was evaluated. Those with a psychiatric comorbid diagnosis, mental 
retardation, and illiterate patients were excluded from the study. Axis I disorders were 
assessed using the Structural Clinical Interview Diagnosis I (SCID-I) research version. 
Patients included in the study were classified into bipolar disorder, 
schizophrenia/schizoaffective disorder, depression, and other disorder (such as adjustment 
disorder, anxiety disorder, dissociative disorder, substance abuse, or impulse control disorder 
– not otherwise specified) groups. 
Data collection tools 
A special form was prepared to collect demographic and clinical data. Patients were asked to 
fill in the form on the day they were discharged from the psychiatry service. 
Sociodemographic features (sex, age, education level, marital status, employment status, place 
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of residence, and household); clinical features and those affecting the course of disease (onset 
of complaints, number of hospitalizations, presence of axis II diagnosis, additional physical 
disease, and cigarette/substance addiction); attendance to follow-up appointments within 6 
months before admission; and reasons of medication nonadherence (not willing to use 
medication, not accepting the disease, being disturbed by side effects, feeling well, not 
knowing how long the medication would be taken, being not aware that the medication would 
be taken regularly, and other reasons) were examined through the said form. Not taking any 
medicine for at least 1 week during the 6-month term before the study was regarded as 
medication nonadherence. This data was supported by the data gathered from first-degree 
relatives and patient files. Non-attendance of at least 20% of the appointments during the 6 
months before the study was regarded as not attending the regular polyclinic follow-ups. This 
data also was supported by the data gathered from first-degree relatives and patient files. 
Statistical analysis 
Data were presented as mean ± standard deviation (SD) and percentage and statistically 
evaluated by SPSS software (v22; IBM Corporation, Armonk, NY, USA). After descriptive 
analysis, independent variables thought to affect the dependent variable medication 
nonadherence, namely age, sex, marital status, education status, smoking, household, place of 
residence, irregular follow-up attendance, and diagnostic parameters, were analyzed by 
logistic regression test. The distribution of the items selected by the cases in a seven-item 
question – multiple answer questions answered as yes/no – examining the reasons of 
medication nonadherence was evaluated using multiple response analysis. P<0.05 was 





The average age of the patients was 36.7±13.2 years. Sociodemographic features are shown in 
Table 1. Ninety-six (47.3 %) of the patients were married, 78 (38.4%) were primary school 
graduates, and 145 (71.4%) were unemployed. One hundred and thirty (64.0%) of the patients 
were residing in downtown, while 97 (47.8%) were living with their mother/father/sibling. 
Table 1 Sociodemographic parameters  
 
Sociodemographic characteristics  
 
n (%)  
 
Sex  
   Female  90 (44.3)  
   Male  113 (55.7)  
Marital status  
   Married  96 (47.3)  
   Single  75 (36.9)  
   Divorced  22 (10.8)  
   Widow  10 (4.9)  
Education status  
   Primary school  78 (38.4)  
   Secondary school  40 (19.7)  
   High school  59 (29.1)  
   University  24 (11.8)  
Employment status  
   Unemployed  145 (71.4)  
   Employed  58 (28.6)  
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Place of residence  
   Village  39 (19.2)  
   County  34 (16.7)  
   City  130 (64.0)  
Households  
   Spouse/children  82 (40.4)  
   Mother/father/sibling  97 (47.8)  
   Nursery  5 (2.7)  
   Alone  17 (9.0)  
   Other  2 (0.1) 
 
 
The median length of total hospitalization at the psychiatry service was 2 days (range: 
0–20), while the mean period for initiation of complaints was 2,776.5±1,012.3 days. There 
were 45 (22.2%) cases with comorbid physical disease, 23 (11.3%) patients with axis II 
diagnosis, and 20 (9.9%) patients with lifelong substance abuse. Cases having a history of 
substance abuse stated that they had not used any substance during the 6-month term before 
hospitalization. Twenty-four (61.1%) of the cases stated that they were smokers. 
It was found that 104 (51.2%) of the patients took their medicines regularly during the 
last 6 months, while 99 (48.8%) patients experienced medication nonadherence. Patients were 
studied under four groups: bipolar disorder (n=68, 33.5%), schizophrenia/schizoaffective 
disorder (n=59, 29.1%), depression (n=39, 19.2%), and other (n=37, 18.2%). The other 
disorders group was composed of cases having adjustment disorder (n=7, 3.2%), anxiety 
disorder (n=4, 2.8%), dissociative disorder (n=7, 3.2%), substance abuse (n=6, 2.7%), and 
impulse control disorder – not otherwise specified (n=10, 5.0%). 
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Medication nonadherence of the study subgroups defined as bipolar disorder, 
schizophrenia/schizoaffective disorder, depression, and other disorders are shown in Table 2. 
Medication nonadherence was significantly higher in the bipolar disorder group when 
compared to other diagnostic groups (12.1%, 18.2%, and 24.2% vs 45.5%; P<0.05). 
Table 3 yielded the following results: items 2, 3, and 1 in bipolar disorder cases, item 
2 in schizophrenia/schizoaffective disorder cases, item 4 in depression cases, and item 3 in 
cases diagnosed with other disorders were found to be significantly important in medication 
nonadherence. 
When the effects of important demographic and clinical parameters listed in Table 4 
were studied by regression analysis by taking medication nonadherence as the dependent 
variable, it was found that age, sex, marital status, education status, smoking, living with 
others, and place of residence had no significant effect on medication nonadherence (P>0.05), 
while irregular follow-up attendance (odds ratio [OR]: 5.7; 95% confidence interval [CI]: 










Table 2 Medication nonadherence in bipolar disorder, schizophrenia/schizoaffective disorder, depression, 














Other (n=37)  Total  
      
Present  45 (45.5%)  24 (24.2%)  12 (12.1%)  18 (18.2%)  99 (100%)  
Absent  23 (22.1%)  35 (33.7%)  27 (26.0%)  19 (18.3%)  104 (100%)  
 
      
Notes: Medication nonadherence was significantly higher in the bipolar group when compared to the other 









Table 3 Feedback related to the reasons of medication nonadherence in bipolar disorder, 
schizophrenia/schizoaffective disorder, depression, and other diagnostic groups  




disorder (n=24)  
Depression (n=12)  Other (n=18)  
     
Item 1: Not willing to 
use medication  
19 (23.2%)  6 (15.85%)  5 (17.9%)  7 (25.9%)  
Item 2: Not accepting 
the disease  
23 (32.9%)  9 (23.7%)  5 (17.9%)  6 (22.2%)  
Item 3: Being 
disturbed by side 
effects  
22 (26.8%)  4 (10.5%)  5 (17.9%)  8 (29.6%)  
Item 4: Feeling well  11 (13.4%)  5 (13.2%)  8 (28.6%)  3 (11.1%)  
Item 5: Not knowing 
how long the 
medication would 
need to be taken for  
1 (1.2%)  4 (10.5%)  1 (3.6%)  0  
Item 6: Not being 
aware that the 
medication needed to 
be taken regularly  
0  6 (15.8%)  2 (7.1%)  2 (7.4%)  
Item 7: Other  2 (2.4%)  4 (10.5%)  2 (7.1%)  1 (3.7%)  
     
Notes: Answers in each diagnostic group are shown as the number and percentage of cases representing each answer. The 
distribution of the items selected by the cases in a seven-item question – multiple answer questions answered as yes/no – 
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examining the reasons of medication nonadherence was evaluated using multiple response analysis. The table yielded the 
following results: items 1, 2, and 3 in bipolar disorder cases, item 2 in schizophrenia/schizoaffective disorder cases, item 4 






Table 4 Odds ratios of the selected demographic and clinical parameters that may affect medication nonadherence 
Dependent variables P-value Odds ratio 95% confidence interval 
Age 0.86 1.0 0.97–1.04 
Sex 0.44 1.3 0.65–2.73 
Marital status 0.77 0.9 0.61–1.44 
Education  0.09 0.3 0.08–1.21 
Smoking 0.50 1.3 0.63–2.58 
Living with others 0.37 0.8 0.58–1.23 
Place of residence 0.55 0.9 0.59–1.32 
Irregular follow-up 
attendance 
0.001 5.7 2.92–11.31 
Diagnosis 0.01 1.5 1.07–1.95 
 
Notes: Logistic regression analysis revealed that diagnosis and irregular follow-up attendance were the variables  had 




In the present study, cases hospitalized at the psychiatry clinic of our hospital were classified 
into bipolar disorder, schizophrenia/schizoaffective disorder, depression, and other disorder 
groups, and medication nonadherence ratios during the last 6 months were examined together 
with the clinical factors affecting medication nonadherence. Sociodemographic features were 
found to have no effect on medication nonadherence. In the study group, the cases had bipolar 
disorder, schizophrenia/schizoaffective disorder, depression, and other disorders. The ratio of 
medication nonadherence was found to be higher in bipolar disorder group when compared to 
the schizophrenia/schizoaffective disorder, depression, and other disorder groups. 
Schizophrenia/schizoaffective disorder, depression, and other disorder groups had similar 
ratios in terms of medication nonadherence. Not willing to use medication, not accepting the 
disease, and being disturbed by side effects in the bipolar group; not accepting the disease in 
schizophrenia/schizoaffective disorder cases; feeling well in depression cases; and being 
disturbed by side effects in other disorder cases were the factors effecting medication 
adherence more when compared to other factors. In general, all the diagnostic groups were 
similar in terms of the ratio of preferring the other items. In logistic regression analysis, age, 
sex, marital status, education status, smoking, living with others, place of residence, irregular 
follow-up attendance, and diagnosis were evaluated as variables having the potential to effect 
medication adherence; of these irregular follow-up (OR: 5.7) and diagnosis (OR: 1.5) were 
found to be the only factors increasing medication nonadherence. The other variables were 
found to have no effect on medication adherence. 
In a study conducted by Scott and Pope, the ratio and reasons of medication 
nonadherence (in mood stabilizers) were evaluated in 98 bipolar disorder cases. The authors 
reported the medication nonadherence ratio as 50% in the previous 2 years and stated that past 
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history of nonadherence, lack of insight, and greater duration of using a medication were the 
factors significantly increasing medical nonadherence, while side effects were not as good as 
attitudes and behaviors in predicting medication nonadherence. Arvilommi et al studied 
clinical features with respect to their effects on medication nonadherence in an 18-month 
prospective study conducted on 168 in- and outpatients with bipolar disorders I and II. The 
authors found that half of the cases had medication nonadherence and reported that the main 
reasons for medication nonadherence were side effects, lack of motivation, and a negative 
attitude. Similar to the literature, we found that nearly half of the bipolar patients in our study 
had medication nonadherence. When the results of the above mentioned studies on bipolar 
disorders are taken into account, the reasons for medication nonadherence could be affected 
by various clinical parameters. In a review in which factors associated with adherence to 
treatment were comprehensively examined in bipolar patients, Leclerc et al classified the 
reasons of poor adherence as follows: patient-related factors (eg, younger age, male sex, low 
level of education, and alcohol and drugs comorbidity), treatment-related factors (eg, side 
effects of medications and effectiveness), and disorder-related factors (eg, younger age of 
onset, severity of BD, insight, and lack of awareness of illness). In our study we also aimed to 
evaluate the diagnostic groups as factors possible to be associated with medication 
nonadherence, the patient-related factors defined by Leclerc et al were not evaluated based on 
diagnostic groups but as independent variables in logistic regression analysis of the whole 
study group. Nonetheless, consistent with literature, in bipolar patients, not willing to use 
medication, not accepting the disease, and being disturbed by side effects came into the 
forefront in our evaluation. 
In a comprehensive review of recent literature, Lacro et al found a mean nonadherence 
rate of 49.5% in patients with schizophrenia. In our study, the ratio of medication 
nonadherence was found to be 24.2% in patients with schizophrenia. This could be related to 
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difference in the study populations, methodology used in terms of definition and measurement 
of adherence, and period of time over which adherence was assessed. The ratio of regular 
medication use is higher in schizophrenia patients when compared to bipolar disorder patients 
(50%–60% vs 35%). Similarly, in our study, the ratio of medication nonadherence was higher 
in bipolar disorder cases when compared to schizophrenia patients. In our study, the ratios of 
those denying their disease were 32.9% and 23.7% in bipolar and 
schizophrenia/schizoaffective disorder patients, respectively. Unal et al stated that 50% of the 
patients lost to follow-up after discharge or those having an irregular attendance to follow-up 
appointments did not have sufficient knowledge of their disorder. In another study, 68.5% of 
the patients were found to stop medication without physician approval due to experiencing 
side effects, believing the medication would not help them recover, and feeling well.  
We examined the reasons of medication nonadherence comprehensively, and observed 
that lack of insight was the major factor in those having bipolar disorder and 
schizophrenia/schizoaffective disorder (32.9% and 23.7%, respectively). In previous cross-
sectional studies, it has been reported that patients with superior insight had better medication 
adherence when compared to those with no insight into their illness. Increasing insight has 
been shown to improve medication adherence. There may be varying levels of disease 
awareness, especially in psychotic patients. In another study, it was found that treatment 
compliance is not related to awareness of mental diseases but is related to an increased 
awareness of clinical symptoms.  
It has been reported that one out of every three patients (34.2%) having a chronic 
psychiatric disorder attends follow-up appointments regularly. Low socioeconomic status, 
younger age, low educational level, history of irregular follow-up, substance abuse, low 
functioning, serious psychiatric problems, problems with communication with their physician, 
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and living far away from treatment centers have been found to be associated with irregular 
follow-up. Not attending follow-up appointments after the first episode can be an indicator of 
medication adherence. Medication adherence can be controlled by asking patients to bring 
their medications with them to the follow-up appointments. The results obtained in our study 
and in previous studies suggest that follow-up appointments contribute to patient–physician 
relations and support medication adherence by increasing insight into illness. 
The strengths of our study are having several diagnostic groups and analyzing 
medication adherence from multiple perspectives. Moreover, a different point of view is 
presented by studying the history of medication nonadherence in inpatients. Limitations of our 
study include: the number of cases in diagnostic groups being relatively less than the number 
of characteristics studied, having a population composed of only inpatients, and being a cross-
sectional study. Starting out from this point, further prospective studies conducted on 
outpatients, having a larger study population where the patients are followed-up for a longer 
time, and including a control group are suggested to be performed. 
In conclusion, the ratio of medication nonadherence is high in patients hospitalized at 
a university hospital setting for bipolar disorder, schizophrenia/schizoaffective disorder, 
depression, and other disorders. Medication nonadherence affects treatment success 
significantly more in bipolar disorder and cases with irregular attendance to follow-up 
appointments. Views of psychiatric patients on medication nonadherence may contribute to 
determining strategies to increase medication adherence and to organize trainings for patients 
and families to decrease medication nonadherence. In the present study, medication 
nonadherence was evaluated through self-report, statements of relatives, and information on 
patient files. It is recommended to evaluate medication adherence in future studies through 
more specific methods such as pill counting and biochemical analysis along with the methods 
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used in the present study. Also, further studies are needed that score medication nonadherence 
in bipolar disorder, schizophrenia/schizoaffective disorder, and depression patients using a 
new scale specific for psychiatric patients and in terms of giving direction to the practice of 
reducing the medication nonadherence. 
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2.1.  TRANSLATION OF THE SOURCE TEXT I  
Pregled razloga nepravilnog uzimanja lijekova kod psihijatrijskih 
pacijenata 
Derya Güliz Mert 




Cilj istraživanja: Ovo istraţivanje provedeno je kako bi se procijenili čimbenici koji utječu 
na nepravilno uzimanja lijekova unutar šest mjeseci prije prijema na psihijatrijsku skrb naše 
bolnice zbog bipolarnoga poremećaja, shizofrenije/shizoafektivnog poremećaja, depresije te 
ostalih psihijatrijskih bolesti. 
 
Pacijenti i metode: U istraţivanje je bilo uključeno dvjesto trideset tri pacijenata zaprimljena 
na psihijatrijsku skrb Medicinskog fakulteta. Proučavali su se sociodemografski parametri i 
klinički nalazi unutar šest mjeseci prije prijema te gledišta pacijenata na razloge nepravilnog 
uzimanja lijekova.  
Rezultati: Pacijenti su bili razvrstani u četiri skupine u skladu s njihovim dijagnozama: 
bipolarni poremećaj (broj ispitanika = 68, 33.5%), shizofrenija/shizoafektivni poremećaj (broj 
ispitanika = 59, 29.1%), depresija (broj ispitanika = 39, 19.2%) i ostali (broj ispitanika = 37, 
18.2%). Omjer nepravilnog uzimanja lijekova bio je veći u skupini bipolarni poremećaj u 
odnosu na skupine sa shizofrenijom/ shizoafektivnim poremećajem, depresijom te ostalim 
poremećajima (12.1%, 18.2% i 24.2% u odnosu na 45.5%), dok je u svim ostalim skupinama 
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omjer bio sličan. Analizom logističke regresije utvrĎeno je kako su neredovito praćenje 
(omjer izgleda [OR]: 5.7; 95% interval pouzdanosti [IP]: 2.92-11.31) te dijagnoza (OR: 1.5; 
95% IP: 1.07-1.95) vaţni čimbenici rizika kod nepravilnog uzimanja lijekova. Vodeći 
čimbenici povezani s nepravilnim uzimanjem lijekova su: „nije voljan uzimati lijekove“, 
„neprihvaćanje bolesti“ i „smetnje uzrokovane nuspojavama“ u skupini bipolarni poremećaj, 
„neprihvaćanje bolesti“ u skupini shizofrenija/shizoafektivni poremećaj, „osjeća se dobro“ u 
skupini depresija te „smetnje uzrokovane nuspojavama“ u skupini ostalih poremećaja.  
Zaključak: Nepravilno uzimanje lijekova značajan je problem kod psihijatrijskih pacijenata i 
njime bi se trebalo baviti uzimajući u obzir dijagnozu, pohaĎanje termina praćenja te 
pacijentov stav. Osiguravanje redovitog pohaĎanja termina praćenja, prilagoĎavanje plana 
voĎenja tretmana prema dijagnozi te poboljšanje njihovog razmišljanja u svezi opiranja 
uzimanja lijekova moţe djelovati blagotvorno na pridrţavanje uzimanja propisane terapije. 
Ključne riječi: bipolarni poremećaj, shizofrenija, shizoafektivni poremećaj, depresija, 
pacijentov stav 
Uvod 
Svjetska zdravstvena organizacija izvijestila je da je omjer nepravilnog uzimanja lijekova kod 
ljudi s kroničnim bolestima oko 50%. Odbijanje liječenja ozbiljan je problem kod 
psihijatrijskih pacijenata, na što nas upućuju podatci dobiveni nedavnim istraţivanjem u 
kojem je utvrĎen omjer odbijanja od čak 20-60%. Odbijanjem liječenja smatra se nepravilno 
uzimanje preporučene doze lijekova te neučestalost uzimanja istih, odbijanje uzimanja 
lijekova uopće te neredovito pohaĎanje termina praćenja ili nepohaĎanje termina uopće. 
Najvaţniji i često susretljiv oblik nepravilnog uzimanja lijekova predstavljaju nepravilno 
uzimanje preporučene doze lijekova te neučestalost uzimanja istih. Omjer nepravilnog 
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uzimanja lijekova je 40%-60% za antipsihotike, 18%-56% za stabilizatore raspoloţenja i 
30%-97% (u prosjeku 63%) za antidepresive. Nadalje, u istraţivanjima koja proučavaju 
nepravilno uzimanje lijekova s obzirom na dijagnozu, omjer nepravilnog uzimanja lijekova je 
12%-64% kod pacijenata s bipolarnim poremećajem, 11%-80% kod pacijenata sa 
shizofrenijom te 30%-60% kod pacijenata koji boluju od depresije.  
 Postoje mnogi čimbenici koji vode k nepravilnom uzimanju lijekova kod 
psihijatrijskih pacijenata, uključujući nesvjesnost o postojanju bolesti, štetni učinak lijekova, 
ometajuće nuspojave koje utječu na kvalitetu ţivota, nedostatak podrške obitelji i društva, 
nedovoljna informiranost o bolesti i liječenju te zloupotreba lijekova ili ovisnost. 
Dijagnostički i statistički priručnik za mentalne poremećaje (DSM)-5 opisuje mnoga stanja 
koja utječu na nepravilno uzimanje lijekova, uključujući prekomjernu teţinu ili pretilost, 
simuliranje, lutanja uzrokovana mentalnim poremećajem te granične intelektualne 
sposobnosti. Nepravilno uzimanje lijekova jedan je od neizbjeţnih razloga koji utječe na 
vraćanje bolesti ili čak smrtnost pacijenata.  
Iz tog razloga, tijekom procjenjivanja pacijenta trebaju se ispitati uzorci nepravilnog uzimanja 
lijekova. Potrebno je detaljno proučiti povijest nepridrţavanja, konzumiranje alkohola ili 
lijekova za vrijeme perioda bez simptoma, doziranje lijekova, višestruko uzimanje lijekova, 
nuspojave te terapeutsko povezivanje. Budući da nepravilno uzimanje lijekova učestalo 
uzrokuje pogoršanje, vraćanje bolesti, ponašanje štetno za sebe ili okolinu, samoubojstvo ili 
ponovno bolničko liječenje, ono ima negativan utjecaj na pacijenta, njegovu obitelj te društvo. 
Kod 20%-25% psihijatrijskih pacijenata bolničko liječenje povezano je s nepravilnim 
uzimanjem lijekova.  
Istraţivanja o nepravilnom uzimanju lijekova koja imaju vaţnu ulogu u liječenju 
psihijatrijskih bolesti te čimbenici povezani s nepridrţavanjem obično upućuju na 
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pojedinačnu dijagnostičku skupinu. U literaturi ne postoji dovoljan broj istraţivanja koja 
usporeĎuju različite dijagnostičke skupine u odnosu na nepravilno uzimanje lijekova. Povrh 
toga, nedovoljan je i broj istraţivanja koja procjenjuju utjecaj osobina pacijenata i čimbenika 
povezanih s bolešću na nepravilno uzimanje lijekova. Dobiveni rezultati o razlozima 
nepravilnog uzimanja lijekova mogu imati značajan utjecaj na bolničko liječenje pacijenata te 
praćenje vanjskih pacijenata. U ovom istraţivanju čimbenici koji rezultiraju nepravilnim 
uzimanjem lijekova unutar šest mjeseci prije prijema na psihijatrijsku skrb naše bolnice zbog 
bipolarnog poremećaja, shizofrenije/ shizoafektivnog poremećaja, depresije i ostalih 
psihijatrijskih poremećaja vrednovani su višedimenzionalnim pristupom. 
Pacijenti i metode 
Ispitanici 
Ovo unakrsno istraţivanje provedeno je na pacijentima koji su zaprimljeni na bolničko 
liječenje u psihijatrijsku kliniku zbog bipolarnog poremećaja, shizofrenije i shizoafektivnih 
poremećaja, depresije te ostalih psihijatrijskih poremećaja. Prije provoĎenja istraţivanja 
dobiveno je odobrenje Etičkog odbora za istraţivanja koja se vrše na ljudskim ispitanicima. 
Svi pacijenti liječeni izmeĎu listopada 2013. i veljače 2014. godine pozvani su da sudjeluju u 
istraţivanju, a oni koji su bili voljni sudjelovati uključeni su u istraţivanje na temelju 
dobivenog pristanka. U istraţivanju se promatrao period od šest mjeseci prije početka studije. 
U istraţivanje nisu bili uključeni pacijenti s višestrukim psihijatrijskim dijagnozama, 
intelektualnom onesposobljenošću te nepismeni pacijenti. Poremećaji po osi I procjenjivani su 
korištenjem istraţivačke tehnike strukturiranog kliničkog intervjua za poremećaje po osi I 
(SKID- I). Pacijenti uključeni u istraţivanje bili su razvrstani u skupine s obzirom na bipolarni 
poremećaj, shizofreniju/shizoafektivni poremećaj, depresiju te ostale poremećaje (kao što su 
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poremećaj prilagodbe, anksioznost, disocijativni poremećaj, zloupotreba lijekova ili 
poremećaj kontrole poriva, nije drugačije specificirano).  
Instrumenti prikupljanja podataka 
Za prikupljanje demografskih i kliničkih podataka pripremljen je poseban obrazac. Od 
pacijenata je zatraţeno da obrazac popune na dan otpuštanja sa psihijatrijske skrbi. Pomoću 
navedenog obrasca proučavale su se sociodemografske karakteristike (spol, dob, stupanj 
obrazovanja, bračni status, zaposlenje, prebivalište, kućanstvo), kliničke te one karakteristike 
koje utječu na tijek bolesti ( početak ţaljenja zbog bolesti, broj bolničkih liječenja, prisustvo 
dijagnoze po osi II, dodatna fizička bolest te ovisnost o cigaretama ili drugim supstancama), 
pohaĎanje termina praćenja unutar šest mjeseci prije prijema te razlozi nepridrţavanja 
uzimanja lijekova (odbijanje uzimanja lijekova, neprihvaćanje bolesti, smetnje uzrokovane 
nuspojavama, osjeća se dobro, neupućenost o duţini perioda uzimanja lijekova, neosviještenost o 
redovitom uzimanju lijekova te drugi razlozi). Nepravilnim uzimanjem lijekova smatra se ne 
uzimanje bilo koje lijeka najmanje jedan tjedan unutar 6-mjesečnog perioda prije istraţivanja. 
Ovi podatci upotpunjeni su informacijama dobivenima ispitivanjem roĎaka u prvom koljenu 
te pomoću medicinskog kartona pacijenta. Neprisustvo na najmanje 20% termina praćenja 
tijekom šest mjeseci prije nego što je istraţivanje započelo vodi se kao ne pohaĎanje 
redovitog kliničkog praćenja. Ovi podatci su takoĎer upotpunjeni informacijama dobivenima 
ispitivanjem roĎaka u prvom koljenu te pomoću medicinskog kartona pacijenta. 
Statistička analiza  
Podatci su prikazani kao prosječna ± standardna devijacija (SD) i postotak te su statistički 
procijenjeni pomoću SPSS programa (verzija 22, IBM korporacija, Armonk, NY, SAD). 
Nakon opisne analize testom logističke regresije analizirali su se dob, spol, bračni status, 
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stupanj obrazovanja, pušenje, kućanstvo, prebivalište, neredovito pohaĎanje termina praćenja 
te dijagnostički parametri, što sve spada u nezavisne varijable za koje se smatra da utječu na 
zavisnu varijablu nepravilnog uzimanja lijekova. Raspodjela stavki po predmetima temeljila 
se na pitanjima sa sedam točaka (pitanja s višestrukim da/ne odgovorima). Na taj način ispitali 
su se razlozi nepravilnog uzimanja lijekova, dok se procjena vršila koristeći višestruku analizu 
odgovora. P<0.05 se smatra statistički značajno.  
Rezultati 
Prosječna dob pacijenta je 36.7±13.2 godina. Sociodemografske karakteristike prikazane su u 
Tablici 1. Devedeset šest (47.3%) pacijenata je u braku, 78 (38.4%) ih je završilo osnovnu 
školu dok ih je 145 (71.4%) nezaposleno. Sto trideset (64.0%) pacijenata ţivi u centru grada 
dok ih 97 (47.8%) ţivi s majkom/ocem/braćom.  
Tablica 1.  Sociodemografski parametri   
 
Sociodemografske karakteristike  
 
Broj ispitanika (%)  
Spol  
   Ţenski  90 (44.3)  
   Muški 113 (55.7)  
Bračni status 
   U braku 96 (47.3)  
   Slobodan 75 (36.9)  
   Rastavljen  22 (10.8)  
   Udovac 10 (4.9)  
Stupanj obrazovanja  
   Osnovna škola 78 (38.4)  
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   Srednja škola  40 (19.7)  
   Gimnazija 59 (29.1)  
   Fakultet 24 (11.8)  
Radni status  
   Nezaposlen 145 (71.4)  
   Zaposlen 58 (28.6)  
Prebivalište  
   Selo 39 (19.2)  
   PredgraĎe  34 (16.7)  
   Grad  130 (64.0)  
Kućanstvo 
   Ţena/djeca  82 (40.4)  
   Majka/otac/braća  97 (47.8)  
   Odgajalište 5 (2.7)  
   Sam  17 (9.0)  
   Drugo 2 (0.1) 
Prosječno trajanje cjelokupnog bolničnog liječenja na psihijatrijskoj skrbi bilo je 2 
dana (raspon: 0-20), dok je prosječan period za upućivanje ţalbi bio 2,776.5±1,012.3 dana. 
Bilo je 45 (22.2%) slučajeva komorbiditeta psihijatrijskih poremećaja, 23 (11.3%) pacijenata 
s dijagnozom po osi II te 20 (9.9%) pacijenata koji dugoročno zloupotrebljavaju opojne droge. 
Slučajevi s poviješću zloupotrebe opojnih droga izjasnili su se kako nisu koristili opojne 
droge unutar 6-mjesečnog perioda prije bolničkog liječenja. Dvadeset četiri (61.1%) slučajeva 
potvrdilo je da su pušači.  
 Otkriveno je kako je 104 (51.2%) pacijenata redovito uzimalo lijekove unazad šest 
mjeseci, dok 99 (48.8%) pacijenata nije. Pacijenti su bili proučavani unutar četiri skupine: 
bipolarni poremećaj (broj ispitanika = 68, 33.5%), shizofrenija/shizoafektivni poremećaj (broj 
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ispitanika = 59, 29.1%), depresija (broj ispitanika = 39, 19.2%) te skupina ostalih poremećaja 
(broj ispitanika = 37, 18.2%). U skupinu ostalih poremećaja bili su uključeni poremećaj 
prilagodbe (broj ispitanika = 7, 3.2%), poremećaj anksioznosti (broj ispitanika = 4, 2.8%), 
disocijativni poremećaj (broj ispitanika = 7, 3.2%), zloupotreba lijekova (broj ispitanika = 6, 
2.7%) te poremećaj kontrole poriva, nije drugačije specificirano (broj ispitanika = 10, 5.0%). 
 Nepravilno uzimanje lijekova kod proučavanih podskupina koje su odreĎene prema 
vrsti poremećaja prikazano je u Tablici 2. Nepravilno uzimanje lijekova bilo je značajnije u 
skupini bipolarni poremećaj usporeĎujući rezultate s ostalim dijagnostičkim skupinama 
(12.1%, 18.2% te 24.2% u odnosu na 45.5%; P<0.05). 
Tablica 3. prikazuje sljedeće rezultate: otkriveno je da su kod nepravilnog uzimanja 
lijekova izrazito vaţne stavke 2, 3 i 1 u slučajevima bipolarnog poremećaja, stavka 2 kod 
slučajeva shizofrenije/shizoafektivnog poremećaja, stavka 4 u slučajevima depresije te stavka 
3 u slučajevima koji su dijagnosticirani kao ostali poremećaji.  
Proučavajući utjecaje vaţnih demografskih i kliničkih parametara navedenih u Tablici 
4., uzimajući nepravilno uzimanje lijekova kao zavisnu varijablu, regresijskog analizom 
utvrĎeno je kako dob, spol, bračni status, stupanj obrazovanja, pušenje, suţivot s drugima te 
prebivalište nemaju značajan utjecaj na nepravilno uzimanje lijekova (P>0.05), dok 
neredovito pohaĎanje termina praćenja (omjer izgleda [RO]: 5.7; 95% interval pouzdanosti 
[IP]: 2.92-11.31) te dijagnoza ( RO: 1.5; 95% IP: 1.07-1.95) imaju povećan utjecaj na 




















ispitanika =39)  
Ostali 
poremećaji (broj 
ispitanika =37)  
Sveukupno  
      
Prisutno 45 (45.5%)  24 (24.2%)  12 (12.1%)  18 (18.2%)  99 (100%)  
Odsutno 23 (22.1%)  35 (33.7%)  27 (26.0%)  19 (18.3%)  104 (100%)  
 
      
Napomena: Nepravilno uzimanje lijekova bilo je značajnije u skupini bipolarni poremećaj usporeĎujući rezultate s ostalim 










Tablica 3. Povratna informacija o razlozima nepravilnog uzimanja lijekova kod bipolarnog poremećaja, 
shizofrenije/shizoafektivnog poremećaja, depresije te ostalih dijagnostičkih skupina 
  





poremećaj ( broj 
ispitanika =24)  
Depresija ( broj 
ispitanika =12)  
Ostali ( broj 
ispitanika =18)  
     
Stavka 1: Odbijanje 
uzimanja lijekova  
19 (23.2%)  6 (15.85%)  5 (17.9%)  7 (25.9%)  
Stavka 2: 
Neprihvaćanje bolesti  




22 (26.8%)  4 (10.5%)  5 (17.9%)  8 (29.6%)  
Stavka 4: Osjeća se 
dobro  
11 (13.4%)  5 (13.2%)  8 (28.6%)  3 (11.1%)  
Stavka 5: 
Neupućenost o duţini 
perioda uzimanja 
lijekova  





0  6 (15.8%)  2 (7.1%)  2 (7.4%)  
Stavka 7: Drugi 
razlozi 
2 (2.4%)  4 (10.5%)  2 (7.1%)  1 (3.7%)  
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Napomena: Odgovori u svakoj dijagnostičkoj skupini prikazani su kao broj te postotak slučajeva za 
svaki odgovor. Raspodjela stavki po predmetima temeljila se na pitanjima sa sedam točaka (pitanja s 
višestrukim da/ne odgovorima). Na taj način ispitali su se razlozi nepravilnog uzimanja lijekova, 
dok se procjena vršila koristeći višestruku analizu odgovora. Tablica prikazuje sljedeće 
rezultate: otkriveno je da su kod nepravilnog uzimanja lijekova izrazito vaţne stavke 2, 3 i 1 u 
slučajevima bipolarnog poremećaja, stavka 2 kod slučajeva shizofrenije/shizoafektivnog 
poremećaja, stavka 4 u slučaju depresije te stavka 3 u slučajevima koji su dijagnosticirani kao 
ostali poremećaji. 
 
Napomena: Analizom logističke regresije otkriveno je kako su dijagnoza i neredovito 
pohaĎanje termina praćenja varijable koje imaju značajan utjecaj na nepravilno uzimanje 
lijekova. 
 
Tablica 4. Omjer izgleda odabranih demografskih i kliničkih parametara koji mogu utjecati na nepravilno uzimanje lijekova 
Zavisne varijable P-vrijednost Omjer izgleda 95% interval pouzdanosti 
Dob 0.86 1.0 0.97–1.04 
Spol 0.44 1.3 0.65–2.73 
Bračni status 0.77 0.9 0.61–1.44 
Stupanj obrazovanja 0.09 0.3 0.08–1.21 
Pušenje 0.50 1.3 0.63–2.58 
Suţivot s drugima 0.37 0.8 0.58–1.23 
Prebivalište 0.55 0.9 0.59–1.32 
Neredovito pohaĎanje 
termina praćenja 
0.001 5.7 2.92–11.31 




U ovom istraţivanju slučajevi zaprimljeni na bolničko liječenje u psihijatrijsku kliniku naše 
bolnice bili su razvrstani u nekoliko skupina, bipolarni poremećaj, shizofrenija/shizoafektivni 
poremećaj, depresija te ostali poremećaji, dok su se omjeri nepravilnog uzimanja lijekova 
tijekom posljednjih šest mjeseci proučavali pomoću kliničkih čimbenika koji utječu na 
nepridrţavanje. Otkriveno je kako sociodemografski čimbenici nemaju utjecaj na nepravilno 
uzimanje lijekova. U ispitivanim skupinama nalazili su se slučajevi s bipolarnim 
poremećajem, shizofrenijom/shizoafektivnim poremećajem, depresijom te ostalim 
poremećajima. Omjer nepravilnog uzimanja lijekova bio je veći u skupini bipolarni poremećaj 
usporeĎujući rezultate s ostalim skupinama. Shizofrenija/shizoafektivni poremećaj, depresija 
te ostali poremećaji imaju sličan omjer u pogledu nepravilnog uzimanja lijekova. U usporedbi 
s ostalim čimbenicima, na nepravilno uzimanje lijekova najviše utječu odbijanje uzimanja 
lijekova, neprihvaćanje bolesti te smetnje uzrokovane nuspojavama u skupini bipolarni 
poremećaj, neprihvaćanje bolesti u skupini shizofrenija/shizoafektivni poremećaj, osjećaj 
zdravlja u skupini depresija te smetnje uzrokovane nuspojavama u skupini ostalih poremećaja. 
Općenito, sve dijagnostičke skupine imale su sličan omjer uzevši u obzir odnos utjecaja 
ostalih stavki. Analizom logističke regresije procijenilo se kako su dob, spol, bračni status, 
stupnja obrazovanja, pušenje, suţivot s drugima, prebivalište, neredovito pohaĎanje termina 
praćenja te dijagnoza stavke koje potencijalno mogu utjecati na uzimanje lijekova. Od 
navedenih stavki utvrĎeno je kako su neredovito pohaĎanje termina praćenja (OV: 5.7) te 
dijagnoza (OV: 1.5) jedini čimbenici koji utječu na povećanje nepravilnog uzimanja lijekova. 
UtvrĎeno je kako ostale varijable nemaju utjecaj na uzimanje lijekova.  
U istraţivanju provedenom od strane Scotta i Popea procjenjivali su se omjer te razlozi 
nepravilnog uzimanja lijekova (stabilizatora raspoloţenja) u 98 slučajeva s bipolarnim 
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poremećajem. Autori su izvijestili kako je omjer nepravilnog uzimanja lijekova u protekle 2 
godine iznosio 50%. TakoĎer tvrde kako su povijest nepravilnog uzimanja lijekova, 
nedostatak uvida u bolest te dulje uzimanje lijekova čimbenici koji značajno utječu na 
povećanje nepravilnog uzimanja lijekova. S druge strane, nuspojave nisu značajne kod 
predviĎanja nepravilnog uzimanja lijekova, dok stavovi i ponašanje jesu. Arvilommi i 
suradnici proučavali su kliničke karakteristike s obzirom na njihov utjecaj na nepravilno 
uzimanje lijekova u 18-mjesečnom prospektivnom istraţivanju provedenom na 168 unutarnjih 
i vanjskih pacijenata s bipolarnim poremećajem stupnja I i II. Autori su otkrili kako se kod 
polovice slučajeva javilo nepravilno uzimanje lijekova te su zaključili kako su glavni razlozi 
za to nuspojave, manjak motivacije te negativan stav. Slično kao i u literaturi, u ovom 
istraţivanju otkrili smo kako polovica bipolarnih pacijenata lijekove ne uzima pravilno. Kada 
se uzmu u obzir rezultati gore navedenog istraţivanja o bipolarnom poremećaju, razlozi 
nepravilnog uzimanja lijekova mogu biti pod utjecajem raznih kliničkih parametara. U 
ispitivanju u kojem su se iscrpno proučavali čimbenici povezani s pridrţavanjem tretmanima 
kod bipolarnih pacijenata, Leclerc i suradnici grupirali su razloge lošeg pridrţavanja 
tretmanima prema čimbenicima povezanim s pacijentom (npr. mlaĎa dob, muški spol, niţi 
stupanj obrazovanja te komorbiditet zloupotrebe alkohola i droga), čimbenicima povezanim s 
liječenjem (npr. nuspojave te učinkovitost lijekova) te čimbenicima poveznim s poremećajem 
(npr. mlaĎa dob kod početka bolesti, jačina bipolarnog poremećaja, uvid u bolest te 
nedostatak svijesti o bolesti). TakoĎer, našim istraţivanjem htjeli smo procijeniti 
dijagnostičke skupine kao čimbenike koji bi se mogli povezati s nepravilnim uzimanjem 
lijekova. Čimbenici povezani s pacijentom, koje su definirali Leclerc i suradnici, nisu bili 
procjenjivani na temelju dijagnostičkih skupina već kao nezavisne varijable analize logističke 
regresije cijele ispitivane skupine. Ipak, u skladu s literaturom, bipolarni pacijenti koji 
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odbijaju uzimati lijekove, ne prihvaćaju bolest te su ometeni nuspojavama stavljeni su u prve 
redove tijekom procjenjivanja.  
U sveobuhvatnom pregledu nedavne literature, Lacro i suradnici odredili su srednju 
stopu nepravilnog uzimanja lijekova od 49.5% kod pacijenata sa shizofrenijom. U ovom 
istraţivanju omjer nepravilnog uzimanja lijekova kod pacijenata sa shizofrenijom bio je 
24.2%. To se moţe pripisati razlikama u ispitivanoj populaciji, metodologiji korištenoj u 
definiranju i mjerenju nepravilnog uzimanja lijekova te periodu u kojem se nepravilno 
uzimanje procenjivalo. Omjer redovitog uzimanja lijekova bio je viši kod pacijenata sa 
shizofrenijom u usporedbi s bipolarnim pacijentima (50%-60% naspram 35%). Na sličan 
način, u ovom istraţivanju, omjer nepravilnog uzimanja lijekova bio je viši u slučajevima 
bipolarnog poremećaja u usporedbi s pacijentima sa shizofrenijom. Ustanovili smo kako je 
omjer onih koji poriču bolest bio 32.9% kod bipolarnih pacijenata odnosno 23.7% kod 
pacijenata sa shizofrenijom/shizoafektivnim poremećajem. Unal i suradnici tvrde kako 50% 
pacijenata koji nisu dolazili na praćenja nakon otpuštanja iz bolnice ili oni koji su dolazili 
neredovito imalo nedovoljna saznanja o svojoj bolesti. U drugom istraţivanju, 68.5% 
pacijenata prestalo je uzimati lijekove bez dozvole liječnika zbog nuspojava, vjerujući kako 
im lijekovi neće pomoći u oporavku te kako se zbog njih neće osjećati bolje.  
Pomno proučavajući razloge nepravilnog uzimanja lijekova uočili smo kako je 
nedostatak uvida u bolest jedan od vodećih čimbenika kod pacijenata s bipolarnim 
poremećajem te shizofrenijom/shizoafektivnim poremećajem (32.9% te 23.7%). U 
prethodnim unakrsnim istraţivanjima utvrĎeno je kako se pacijenti koji su svjesniji svoje 
bolesti dosljednije pridrţavaju terapiji u odnosu na one koji nemaju saznanja o bolesti. 
Pokazalo se kako povećano saznanje o bolesti poboljšano utječe na uzimanje lijekova. Razine 
svijesti o bolesti mogu varirati, osobito kod psihotičnih pacijenata. U jednom drugom 
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istraţivanju uočeno je kako prihvaćanje liječenja nije povezano s osviještenošću o mentalnoj 
bolesti već ovisi o povećanom shvaćanju kliničkih simptoma. 
UtvrĎeno je da je redovito pohaĎanje termina praćenja prisutno kod jednog od tri 
pacijenta (34.2%) koji boluju od kroničnih psihijatrijskih poremećaja. Loš socioekonomski 
status, mlaĎa dob, niţi stupanj obrazovanja, povijest neredovitih dolazaka na tretmane 
praćenja, zloupotreba opojnih droga, niski stupanj funkcioniranja, ozbiljni psihijatrijski 
problemi, problemi komuniciranja s liječnikom te udaljenost mjesta stanovanja od mjesta gdje 
se vrši praćenje neki su od čimbenika koji se povezuju s neredovitim dolascima na termine 
praćenja. Nedolazak na termine praćenja nakon prvog termina moţe biti indikator nepravilnog 
uzimanja lijekova. Nepravilno uzimanje lijekova moţe se kontrolirati tako da se pacijenta 
zamoli da na termine praćenja uzima svoje lijekove. Rezultati dobiveni u ovom, ali i prošlim 
istraţivanjima, ukazuju na to kako dogovoreni termini praćenja doprinose stvaranju odnosa 
izmeĎu pacijenta i liječnika te potiču uzimanje lijekova kroz povećanje svijesti o bolesti.  
Vjerodostojnost ovog istraţivanja očitava se u korištenju nekoliko dijagnostičkih 
skupina te u multidimenzionalnom analiziranju nepravilnog uzimanja lijekova. Povrh toga, 
proučavanjem povijesti nepravilnog uzimanja lijekova kod bolesnika koji se liječe u bolnici 
prikazana su različita gledišta o uzimanju lijekova. Ograničenja ovog istraţivanja uključuju 
unakrsno provoĎenje istraţivanja te relativno manji broj slučajeva u dijagnostičkim 
skupinama negoli broj proučavanih čimbenika. TakoĎer, u istraţivanje su bili uključeni samo 
pojedinci koji su se liječili u bolnici.  
 S tog gledišta, buduća prospektivna istraţivanja trebala bi biti provoĎena na 
pacijentima koji se ne liječe u bolnici. TakoĎer, istraţivanje bi trebalo imati veću studijsku 
populaciju koja uključuje pacijente praćene kroz duţi period te bi se u istraţivanje trebala 
uključiti kontrolna skupina.   
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U zaključku, omjer nepravilnog uzimanja lijekova kod pacijenata koji se liječe u 
sveučilišnoj bolnici zbog bipolarnog poremećaja, shizofrenije/shizoafektivnog poremećaja, 
depresije te ostalih poremećaja smatra se visokim. Nepravilno uzimanje lijekova znatno više 
utječe na uspješnost tretmana kod pacijenata s bipolarnim poremećajem te kod slučajeva koji 
neredovito pohaĎaju termine praćenja. Gledišta psihijatrijskih pacijenata na nepravilno 
uzimanje lijekova mogu doprinijeti odreĎivanju strategija za povećanje pridrţavanja uputa za 
uzimanje lijekova te organiziranju treninga za pacijente i članove obitelji kako bi se smanjilo 
nepravilno uzimanje lijekova. U ovom istraţivanju nepravilno uzimanje lijekova bilo je 
procjenjivano pomoću izvještaja pacijenata, izjava roĎaka te pomoću medicinskog kartona 
pacijenata. Kako bi se procijenilo uzimanje lijekova u budućim istraţivanjima, preporučuju se 
posebne metode kao što su brojanje tableta te biokemijska analiza, uključujući i metode 
korištene u ovom istraţivanju. TakoĎer, potrebna su daljnja istraţivanja koja biljeţe 
nepravilno uzimanje lijekova kod pacijenata koji boluju od bipolarnog poremećaja, 
shizofrenije/shizoafektivnog poremećaja te depresije koristeći novu ljestvicu specifičnu za 
psihijatrijske bolesnike. Uz to, buduća istraţivanja trebala bi rezultirati davanjem uputa za 
proceduru smanjivanja nepravilnog uzimanja lijekova. 
Zahvale 
Autori ţele zahvaliti svim pacijentima te medicinskom osoblju uključenom u istraţivanje.  
Priopćenje 





2.2 COMMENTARY AND ANALYSIS 
SOURCE TEXT I: Perspectives on reasons of medication nonadherence in psychiatric 
patients 
Genre: Medical research 
Source: Journal of Patient Preference and Adherence 
Reference: Mert, D.G., Turgut, N.H., Kelleci, M., Semiz, M. (2015). Perspectives on 
reasons of medication nonadherence in psychiatric patients. Journal of Patient 
Preference and Adherence 
Audience: Medical community (psychiatrists, doctors and the rest of the medical staff) 
Purpose of writing: The research is conducted in order to familiarise the medical community 
with reasons of medication nonadherence in psychiatric patients. As it is stated in this text, 
there is insufficient number of research dealing with this topic. Extensive knowledge about 
medication nonadherence can be used to encourage psychiatric patients to take the prescribed 
medication.  
Authenticity: Considering the fact that the research was conducted by the experts in the field 
of medicine, we can conclude that this work is authentic. This claim can be supported with a 
few more confirmations. The text was published in a well-known medical journal “Patient 
Preference and Adherence“ and the company Dove Medical Press, specialized in scientific 
and medical research, confirmed the authenticity of the text.  
Style: Writing style of this text is expository. The authors explained how the research was 
conducted without giving their own personal opinion. Furthermore, they used a great deal of 
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supporting details, facts and figures in order to validate the obtained results. There is no 
jargon and cliche vocabulary, and the tone of the text is rather formal.  
Level of formality: Highly formal (academic writing; writing methods follow all of the 
accepted language principles; no colloquial expressions; appropriate for academic setting) 
Layout: A standard research layout. At the beginning there is a short summary of the research 
(purpose, patients and methods, results, conclusion and keywords). Summary is followed by 
an introduction and the main part of the research. At the end of the text the authors extricated 
the results of the research and compared them with other similar research in the discussion 
section. The main sections are visibly separated from the rest of the text by using larger font 
and bold letters in the titles. Subtitles are also written in larger font but without usage of bold 
letters. After the discussion there is a part which includes acknowledgments and disclosure. 
At the end of the text the authors have cited the sources used in their work.  
Content: The first part of the text includes the short summary statement (purpose, patients and 
methods, results, conclusions and keywords). After the short summary, there is an 
introduction section. In this section the reader gets familiarised with the basic facts about the 
topic. In the main section (“Patients and methods”) the authors provide additional information 
about the study population, data collection tools and statistical analysis. The last part of the 
text includes the results and discussion sections. In the results section the authors interpret the 
outcome of the research, while in the discussion section they compare their results with other 
similar research. 
Cohesion: The whole text is well integrated. The authors use the same terminology 
throughout the text. The key terms (such as “medication nonadherence”) are used in the same 
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context from the beginning to the end. With this repetition of the same terminology, the 
authors create the lexical cohesion of the text.  
Sentence patterns: The text is composed mostly of compound and complex sentences. 
Sentences are written according to the specific rules and standards of academic writing 
(appropriate vocabulary, correctly used punctuation, subject-verb agreement, etc.). Authors 
avoid using ambiguous references in their sentences (such as this or they) and they follow all 
the grammar rules. They use past tense while reporting due to the fact that the research was 
conducted in the past. 
Terminology of the subject: Medical terminology (such as “medication nonadherence”, 
“bipolar disorder”, “schizophrenia/schizoaffective disorder”, “depression”, etc.). Besides 
medical terminology, the authors use a few terms connected with statistics (“logistic 
regression analysis”, “confidence interval”, etc.). In the discussion part the authors use a Latin 
abbreviation “et al”, which means “and others”.  The terms used in this research are closely 
related to the topic. 
The translation of this research was quite a demanding task. Some of the terms used in this 
research were troublesome to translate due to the fact there are no equivalent expressions in 
the target language. In order to transfer the authors´ ideas properly into the target language, it 
was necessary to consult various medical dictionaries and articles with similar topics. It was 
particularly important to translate all the medical expressions accurately because there is a 
repetition of the same terminology throughout the whole research. If only one term is used in 
the wrong context, the whole translation loses its value.  
The topic of the research is medication nonadherence. While translating this term, I came 
across a few difficulties. We cannot translate the term as “neuzimanje lijekova” because there 
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is no such expression in the medical literature. Croatian experts in the field of medicine 
mostly use the terms “neuredno uzimanje lijekova”, “nepravilno uzimanje lijekova”, 
“nepridrţavanje uzimanja lijekova”, “neprimjereno uzimanje lijekova”, “nepridrţavanje uputa 
o pravilnom uzimanju lijekova”, etc. I choose the second term because I think it is the most 
suitable one for this context. The last term “nepridrţavanje uputa o pravilnom uzimanju 
lijekova” is rather too long and its usage could be inappropriate because the term is used 
repeatedly throughout the whole text.  
Furthermore, authors have focused on just few disorders while conducting this research. I was 
already familiar with some of the terms such as bipolar disorder and depression, but the term 
schizoaffective disorder was new to me. In order to use the appropriate Croatian equivalent, I 
consulted the “MSD priručnik dijagnostike i terapije”. 
Besides few terms closely related to the field of medicine, translation of some other phrases 
was problematic as well. The authors listed few factors for medication nonadherence such as 
“not accepting the disease”, and “being disturbed by side effects”. I translated those terms as 
nouns (“neprihvaćanje“, “smetnje uzrokovane nuspojavama“). On the other hand, translating 
the phrase “feeling well“ as a noun phrase would be inadequate (for example: “osjećaj 
zdravlja“; “osjećaj boljitka“) so I decided to use the verb phrase instead (“ne osjeća se dobro“) 
because it fits in the context of the text. Another debatable phrase to translate was “follow-up 
appointments“. In Croatian language there is no single expression that could convey the 
meaning of the original phrase. In the interest of transferring the correct meaning, but 
respecting the tone, style and the formality level of the text, in the first version of the 
translation I used the phrase “dolazak na termine praćenja“. Since this is a highly formal text, 
I have decided to use more appropriate phrase - “pohaĎanje termina praćenja“.  
 40 
 
Translating requires special effort when it comes to translating the names of organisations, 
books, etc. For example, when we are translating the term “The World Health Organization“, 
we should bear in mind that in the source language there is a capitalisation of every word in 
the names of some organisations. But that is not the case in the target language because the 
appropriate translation is “Svjetska zdravstvena organizacija“ (only the first letter is 
capitalised). There is a similar case with the names of books. For example, in the source 
language the name of the manual is “Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-V“ (we can notice the capitalisation) while in the target language only the first word is 
capitalised (“Dijagnostički i statistički priručnik za mentalne poremećaje (DSM)-5“). While 
translating the name of this manual, I stumbled upon a few different translations of the title 
(“Dijagnostički i statistički priručnik za duševne poremećaje“, “Dijagnostički i statistički 
priručnik za psihičke poremećaje“ and “Dijagnostički i statistički priručnik za mentalne 
poremećaje“). The terms “duševni poremećaj“, “psihički poremećaj“ and “mentalni 
poremećaj“  have the same connotations, but I have decided to use the last example 
(“Dijagnostički i statistički priručnik za mentalne poremećaje“) because I discovered that in a 
few different articles, books and dissertations the staff of the University of Zagreb School of 
Medicine use this translation of the title. Considering the fact that they are the experts in the 
filed of the medicine, I took over their translation of the manual.  
Moreover, in order to improve my translation I decided to examine several articles with 
similar topics. The purpose of this examination was to use the same terminology in my 
translation as it was used in all the other studies. For example, I have found that the 
translation of the phrase “study population” is “ispitanici”, and that the “purpose” cannot be 
translated as “svrha istraţivanja” but as “cilj istraţivanja”. Besides that, this examination gave 
me an insight into the style and tone of academic writing of the target language.  
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Apart from medical terminology, authors used statistical terms while explaining the method of 
data processing. Some of the used terms are “Structural Clinical Interview Diagnosis I (SCID-
I)“, “logistic regression test“, “odds ratio, “confidence interval“, etc. I have encountered some 
of these terms for the first time and in order to translate them as correct as possible I consulted 
various texts of similar topics written in the target language. I translated the name of the 
interview with the help of “Vodič za korisnike za Strukturirani klinički intervju za poremećaje 
s Osi I iz DSM-IV, klinička verzija“. While studying the materials of Faculty of Economics & 
Business Zagreb and other related faculties, I came across the translation of the term “logistic 
regression test” as “analiza logističke regresije”.  
The term “odd ratio” and its abbreviation were quite tricky to translate. While examining the 
statistical terms of the target language, I came across the translation “relativni omjer”, “omjer 
vjerojatnosti” and “omjer izgleda”. Due to the fact that my knowledge of the statistical terms 
was not so extensive, I consulted Biochemia Medica “The journal of Croatian Society of 
Medical Biochemistry and Laboratory Medicine”. In one of the published works, I have found 
that the term is officially translated as “omjer izgleda” (“...omjer izgleda (engl. odds ratio, 
OR) je jedan od nekoliko statističkih testova...”). Throughout this work the authors used the 
English abbreviation of the term so I decided to do the same in my translation. Consulting the 
same journal, I have found the translation of the term “confidence interval”.  
Another obstacle I have stumbled upon while translating was the abbreviation “p”. Reading 
through the articles of the similar topics in the target language, I came across the same 
abbreviation, but there was no explanation of its meaning. Some authors use only the 
abbreviation, while others use “P vrijednost”. Professor Ozren Polašek explains that the 
meaning of the abbreviation is probability of the accuracy of the obtained result. In English 




In the translation process, translation of some terms can be quite confusing. For example, 
while translating the terms “overweight and obesity” I was not sure which word denotes 
which meaning because both terms refer to the weight higher than the average. After 
consulting few health articles, I found out that the term “overweight” indicates having 10% 
more pounds than your optimal weight should be, while the term “obesity” includes 
everything above that percentage.  
 Due to the fact that this is a highly formal text, the structure of sentences is quite complex. 
While translating it was difficult to adhere to the original structure of the sentence. For 
example, while translating the sentence “ The distribution of the items selected by the cases in 
a seven-item question – multiple answer questions answered as yes/no – examining the 
reasons of medication nonadherence was evaluated using multiple response analysis.” I 
decided to detach the part after the hyphen as a separate sentence because it is unusual to 
combine two sentences with a hyphen in the target language.  
Besides that, I often used inversion in my translation because the sentence patterns of the 
source language are not the same as the sentence patterns of the target language. One of the 
principles of translating is to adhere to the original text, but if the structure of the sentence is 
uncommon or it sounds odd, the translator needs to adapt the translation to the target 
language. It means that he or she is allowed to use an inversion or even divide one sentence 
into two separate parts, but he or she needs to bear in mind that the meaning of the translated 







3. SOURCE TEXT II:  
 Overview of the U.S. Health Care System  
Written by Kao-Ping Chua  
AMSA Jack Rutledge Fellow 2005-2006  




The U.S. health care system is the subject of much polarizing debate. At one extreme are 
those who argue that Americans have the “best health care system in the world”, pointing to 
the freely available medical technology and state-of-the-art facilities that have become so 
highly symbolic of the system. At the other extreme are those who berate the American 
system as being fragmented and inefficient, pointing to the fact that America spends more on 
health care than any other country in the world yet still suffers from massive uninsurance, 
uneven quality, and administrative waste.  
 
Understanding the debate between these two diametrically opposed viewpoints requires a 
basic understanding of the structure of the U.S. health care system. This primer will explain 
the organization and financing of the system, as well as place the U.S. health care system in a 
greater international context.  
 
ORGANIZATION OF U.S. HEALTH CARE SYSTEM  
As with all other countries, there are both private and public insurers in the U.S. health care 
system. What is unique about the U.S. system in the world is the dominance of the private 
element over the public element.  
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In 2003, 62% of non-elderly Americans received private employer-sponsored insurance, and 
5% purchased insurance on the private non group (individual) market. 15% were enrolled in 
public insurance programs like Medicaid, and 18% were uninsured. Elderly individuals aged 
65 or over are almost uniformly enrolled in Medicare.  
 
Public Health Insurance 
• Medicare 
o Basics: Medicare is a federal program that covers individuals aged 65 and over, as 
well as some disabled individuals. 
o Administration: Medicare is a single-payer program administered by the 
government; single-payer refers to the idea that there is only one entity (the 
government) performing the insurance function of reimbursement. 
o Financing: Medicare is financed by federal income taxes, a payroll tax shared by 
employers and employees, and individual enrollee premiums (for parts B and D). 
o Benefits: Medicare Part A covers hospital services, Medicare Part B covers 
physician services, and Medicare Part D offers a prescription drug benefit. [Medicare 
Part C refers to Medicare Advantage – HMO’s that administer Medicare benefits]. 
 There are many gaps in Medicare coverage, including incomplete coverage 
for skilled nursing facilities, incomplete preventive care coverage, and no 
coverage for dental, hearing, or vision care. Because of this, the vast 
majority of enrollees obtain supplemental insurance. Overall, seniors pay 





o Basics: Medicaid is a program designed for the low-income and disabled. By federal 
law, states must cover very poor pregnant women, children, elderly, disabled, and 
parents. Childless adults are not covered, and many poor individuals make too much to 
qualify for Medicaid. 
 States have the option of expanding eligibility if they so choose. For 
example, states can choose to increase income eligibility levels. 
o Administration: The states and the District of Columbia are responsible for 
administering the Medicaid program; as such, there are effectively fifty-one different 
Medicaid programs in the country. 
o Financing: Medicaid is financed jointly by the states and federal government through 
taxes. Every dollar that a state spends on Medicaid is matched by the federal 
government at least 100%. In poorer states, the federal government matches each 
dollar more than 100%. Overall, the federal government pays for 57% of Medicaid 
costs. 
o Benefits: Medicaid offers a fairly comprehensive set of benefits, including 
prescription drugs. Despite this, many enrollees have difficulty finding providers that 
accept Medicaid due to its low reimbursement rate. 
• Other public systems 
o S-CHIP: The State Children’s Health Insurance Program (S-CHIP) was designed in 
1997 to cover children whose families make too much money to qualify for Medicaid 
but make too little to purchase private health insurance. S-CHIP and Medicaid often 
share similar administrative and financing structures. 
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o VA: The Veteran’s Administration is a federally administered program for veterans 
of the military. Health care is delivered in government-owned VA 
hospitals and clinics. The VA is funded by taxpayer dollars and generally offers 
extremely affordable (if not free) care to veterans. 
Private Health Insurance 
• Employer-sponsored insurance 
o Basics: Employer-sponsored insurance represents the main way in which Americans 
receive health insurance. Employers provide health insurance as part of the benefits 
package for employees. 
o Administration: Insurance plans are administered by private companies, both for-
profit (e.g. Aetna, Cigna) and non-for-profit (e.g. Blue Cross/Blue Shield). 
 A special case is represented by companies that are “self-insured” – that is, 
they pay for all health care costs incurred by employees directly. In this 
case, the company contracts with a third party to administer the health 
insurance plan. Self-insured companies tend to be larger companies such as 
General Motors. 
o Financing: Employer-sponsored insurance is financed both through employers (who 
usually pay the majority of the premium) and employees (who pay the remainder of 
the premium). In 2005, the annual private employer-sponsored insurance premiums 
averaged $4,024 for single coverage and $10,880 for a family of four.5 
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o Benefits: Benefits vary widely with the specific health insurance plan. Some plans 
cover prescription drugs, while others do not. The degree of cost-sharing (co-pays and 
deductibles) varies considerably. 
• Private non-group (individual market) 
o Basics: The individual market covers part of the population that is self-employed or 
retired. In addition, it covers some people who are unable to obtain insurance through 
their employer. In contrast to the group market (employment-based insurance), the 
individual market allows health insurance companies to deny people coverage based 
on pre-existing conditions. 
o Administration: The plans are administered by private insurance companies. 
o Financing: Individuals pay an insurance premium out-of-pocket for coverage. Risk 
in the individual market depends only on the health status of the individual, in contrast 
to the group market, in which risk is spread out among multiple individuals. As such, 
low-risk, healthy patients will have a low premium, whereas the opposite is true for 
high-risk, sick patients. 
o Benefits: Benefits vary widely with the specific health insurance plan. 
FINANCING OF THE U.S. HEALTH CARE SYSTEM 
The financing of health care centers around two streams of money: the collection of money 
for health care (money going in), and the reimbursement of health service providers for health 
care (money going out). In the United States, the responsibility for these two functions is 
shared by private insurance companies as well as the government, both of which are known in 




• Individuals and businesses 
o Taxes: Both individuals and businesses pay income taxes to the government. In 
addition, there is a payroll tax on employers and employees to finance Medicare. 
o Premiums: Businesses pay all or most of the premium for employer-based insurance 
for employees, and employees pay the remainder. On the individual market, 
individuals pay for all premiums out of pocket. Employer-based insurance premiums 
and individual insurance premiums are collected by private insurers. 
o Direct or out-of-pocket payments: This is a direct payment to a provider for health 
care services (e.g. a co-payment). 
• Government 
o Medicare, Medicaid, S-CHIP, and the VA: The government uses money generated f
 rom taxes to reimburse providers who take care of patients enrolled in these programs. 
o Public employees’ premiums: The government also uses tax dollars to pay private 
insurers a health insurance premium for federal employees and other public 
employees. 
o Tax subsidy: There is a tax subsidy of employer-based insurance (not shown in the 
graph) that represents a major cost to the government (on the order of $100 billion). 
Employees receive health insurance benefits as tax-free compensation, and employers 
are able to deduct health insurance benefits as a cost of doing business. [Since 
employers are only taxed on profits, defined as any income above the cost of doing 
business, being able to deduct health insurance benefits as a cost of doing business is a 
tax subsidy for employers]. 
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• Private insurers 
o Private insurers accept premiums from individuals, businesses, and the government. 
In turn, they reimburse providers for taking care of patients with private insurance. 
• Health service providers 
o Providers (doctors, allied health professionals, hospitals, and other health care 
facilities) take care of individuals. They are reimbursed for their services by private 
insurers and the government. 
In 2002, government expenditures accounted for 44.9% of healthcare costs in the United 
States, and private expenditures accounted for the remaining 55.1%.6 The U.S. spent $1.7 
trillion on health care expenditures in 2003. Of the $1.7 trillion used on health care, the 
majority went to hospital care and physician/clinical services. 
THE U.S. HEALTH CARE SYSTEM IN AN INTERNATIONAL CONTEXT 
[Note: This is taken directly from “OECD Health Data 2005: How Does the United States 
Compare”7]. 
Health spending and financing 
The United States spent 15% of its GDP on health care in 2003, the highest percentage in the 
OECD (an organization of industrialized countries). The average percentage of GDP spent on 
health care in OECD countries was 8.6%. The United States also spends more on health care 
per capita than any other OECD country. In 2003, total health spending per capita was $5,635 
US dollars (adjusted for purchasing power parity), more than twice the OECD average of 
$2,307 US dollars. 
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Between 1998 and 2003, health spending per capita in the United States increased in real 
terms by 4.6% per year on average, a growth rate comparable to the OECD average of 4.5% 
per year. 
The public sector is the main source of health funding in all OECD countries, except for the 
United States, Mexico and Korea. In the United States, 44% of health spending is funded by 
government revenues, well below the average of 72% in OECD countries. 
In the United States, private insurance accounts for 37% of total health spending, by far the 
largest share among OECD countries. Canada, France, and the Netherlands also have a 
relatively large share of funding coming from private insurance (more than 10%). 
Resources in the health sector (human, physical) 
• In 2002, the United States had 2.3 practicing physicians per 1000 population, below 
the OECD average of 2.9 per 1000 population. 
• There were 7.9 nurses per 1000 population in the United States in 2002, below the 
OECD average of 8.2 per 1000 population. 
• The number of acute care hospital beds in the United States in 2003 was 2.8 per 1000 
population, below the OECD average of 4.1 beds per 1000 population. 
Health status and risk factors 
Most OECD countries have enjoyed large gains in life expectancy over the past 40 years. In 
the United States, life expectancy at birth increased by 7.3 years between 1960 and 2002, 
which is less than the increase of 14 years in life expectancy in Japan, or of 8.4 years in 
Canada. In 2002/3, life expectancy in the United States stood at 77.2 years, below the OECD 
 51 
 
average of 77.8 years. Japan, Iceland, Spain, Switzerland and Australia were among the top 5 
countries registering the highest life expectancy among OECD countries. 
Infant mortality rates in the United States have fallen greatly over the past few decades, but 
not as much as in most other OECD countries. In 2002, the infant mortality rate in the U.S. 
was 7 deaths per 1,000 live births, above the OECD average of 6.1. Among OECD countries, 
infant mortality is the lowest in Japan and in the Nordic countries (Iceland, Sweden, Finland 
and Norway), which all have infant mortality rates below 3.5 deaths per 1,000 live births. 
In the United States, the proportion of smokers among adults has fallen from 33.5% in 1980 
to 17.5% in 2003, the lowest rate among OECD countries along with Canada and Sweden. In 
the United States, the obesity rate among adults (30.6% in 2002) is the highest in OECD 













3.1. TRANSLATION OF THE SOURCE TEXT II 
Pregled sustava zdravstvene skrbi SAD-a 
Napisao: Kao-Ping Chua 
AMSA Jack Rutledge Fellow 2005.-2006. 
10. veljače 2006. 
UVOD 
 
Sustav zdravstvene skrbi SAD-a u velikoj je mjeri predmet polarizirajuće rasprave. S jedne 
strane nalaze se oni koji tvrde kako Amerikanci imaju „najbolji sustav zdravstvene skrbi u 
svijetu“, ističući tako slobodno dostupnu medicinsku tehnologiju te najmodernije objekte koji 
su postali simbolima njihovog sustava. S druge strane nalaze se oni koji ljutito kritiziraju 
američki sustav zbog fragmentiranosti i neučinkovitosti, na što ukazuje činjenica kako SAD 
troši više na zdravstvenu skrb negoli bilo koja druga zemlja na svijetu, a ipak se još uvijek 
bori s golemim brojem zdravstveno neosiguranih pojedinaca, neravnomjernom kvalitetom te 
administrativnim gubitcima.  
 
Kako bi razumjeli raspravu izmeĎu ova dva dijametralno oprečna stajališta, potrebno je 
osnovno predznanje strukture sustava zdravstvene skrbi SAD-a. Ovaj uvodni članak će 
objasniti organizaciju i financiranje sustava, kao i mjesto sustava zdravstvene skrbi SAD-a u 






ORGANIZACIJA SUSTAVA ZDRAVSTVENE SKRBI SAD-a 
Kao i u svim ostalim zemljama, sustav zdravstvene skrbi SAD-a sastoji se od privatnih i 
javnih osiguravatelja. Ono što američki zdravstveni sustav izdvaja od ostalih zemalja svijeta 
je prevlast privatnog nad javnim sektorom.  
 
Privatno osiguranje pod pokroviteljstvom poslodavca 2003. godine primilo je 62% 
Amerikanaca mlaĎe dobi, dok ih je 5% kupilo osiguranje na privatnom, negrupiranom 
(pojedinačnom) trţištu. U programe javnog osiguranja kao što je Medicaid (op.prev. naziv 
programa) bilo je uključeno 15% pojedinaca, dok ih je 18% bilo neosigurano. Osobe od 65 i 
više godina gotovo su podjednako uključene u program Medicare (op.prev. naziv programa). 
Javno zdravstveno osiguranje 
• Medicare 
o Osnove: Medicare je savezni program koji uključuje pojedince od 65 i više godina, 
kao i pojedine osobe s invaliditetom. 
o Administracija: Medicare je program pod upravom Vlade, a djeluje na principu 
samo jednog obveznika, što se odnosi na ideju da postoji samo jedan entitet (Vlada) 
koji obavlja funkciju nadoknade osiguranja.  
o Financiranje: Program Medicare se financira putem saveznog poreza na dohodak, to 
jest putem takozvanog poreza na isplatne liste poslodavaca i zaposlenika te putem 
individualnih premija za individue uključene u plan zdravstvenog osiguranja (za 
dijelove B i D).  
o Prednosti: Dio A Medicare programa pokriva bolničke usluge, Dio B Medicare 
programa pokriva liječnike usluge dok Dio D Medicare programa puţa naknadu za 
lijekove na recept [ Dio C Medicare programa odnosi se na „Medicare Advantage 
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plan“ (op.prev. naziv djela programa) organizacije zdravstvene zaštite koja upravlja 
pogodnostima Medicare programa]. 
 Postoje mnoge nedostatci Medicare programa, uključujući nepotpunu 
pokrivenost za kvalificirane domove za njegu, nepotpunu preventivnu skrb 
te neobuhvaćanje zdravstvene skrbi za njegu zubiju, sluha te vida. Upravo 
zbog toga velika većina individua uključenih u plan zdravstvenog 
osiguranja ţeli se izboriti za dopunsko osiguranje. Sve u svemu, ljudi treće 
ţivotne dobi plaćaju oko 22% od svojih prihoda za troškove zdravstvenog 
osiguranja unatoč činjenici da su uključeni u Medicare program. 
• Medicaid 
o Osnove: Medicaid je program osmišljen za osobe s invaliditetom te niskim 
prihodima. Po saveznom zakonu drţave moraju pokrivati osiguranje za osobe slabijeg 
imovinskog statusa, što uključuje trudnice, djecu, starije, osobe s invaliditetom te 
roditelje. Odrasli bez djece nisu pokriveni programom, dok mnogi pojedinci slabijeg 
imovinskog statusa zaraĎuju previše da bi ostvarili pravo za Medicaid.  
 Ako to ţele, drţave imaju mogućnost proširenja ispunjavanja uvjeta. Na 
primjer, drţave mogu odlučiti o povećanju razine prihoda koji su potrebni 
za ispunjavanje uvjeta.  
o Administracija: Drţave te okrug Columbia odgovorne su za administriranje 
Medicaid programa te sukladno tome u zemlji učinkovito djeluje pedeset jedan različit 
Medicaid program. 
o Financiranje:  Medicaid je financiran zajednički od strane drţava te federalne vlade 
putem poreza. Svaki dolar koji drţava potroši na Medicaid, federalna vlada 
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upotpunjuje s najmanje 100%. U siromašnijim zemljama, federalna vlada upotpunjuje 
svaki dolar s više od 100%. Sveukupno federalna vlada plaća 57% troškova Medicaid 
programa.  
o Prednosti: Medicaid nudi prilično sveobuhvatan skup pogodnosti, uključujući 
lijekove na recept. Unatoč tome, mnoge individue uključene u plan zdravstvenog 
osiguranja susreću se s poteškoćama u pronalaţenju davatelja usluga koji prihvaćaju 
Medicaid zbog niske stope naknade.  
• Ostali javni sustavi 
o S-CHIP: The State Children’s Health Insurance Program (S-CHIP) (op.prev. naziv 
programa) osmišljen je 1997. godine kako bi se osigurala djeca onih roditelja čija su 
primanja iznad razine za ostvarivanje prava na Medicaid, ali istovremeno zaraĎuju 
premalo za kupnju privatnog zdravstvenog osiguranja. S-CHIP i Medicaid često dijele 
slične administrativne i financijske strukture.  
o VA: The Veteran’s Administration (op.prev. naziv programa) je vladin program za 
vojne veterane. Zdravstvena skrb se pruţa u bolnicama i klinikama drţavnog 
vlasništva za VA programe. VA se financira od strane poreznih obveznika i u pravilu 
pruţaju izuzetno povoljnu (ako ne i besplatnu) zdravstvenu skrb za veterane.  
Privatno zdravstveno osiguranje 
• Osiguranje pod pokroviteljstvom poslodavca 
o Osnove: Osiguranje pod pokroviteljstvom poslodavca predstavlja glavni način na 
koji Amerikanci primaju zdravstveno osiguranje. Poslodavci pruţaju zdravstveno 
osiguranje kao dio paketa pogodnosti za zaposlenike.  
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o Administracija:  Planovi osiguranja upravljani su od strane privatnih tvrtki, kako za 
profitne (na primjer: Aetna, Cigna) tako i za neprofitne organizacije ( na primjer: Plavi 
kriţ/Plavi štit).  
 Poseban slučaj predstavljaju „samoosiguravajuće“ tvrtke koje direktno 
plaćaju sve troškove zdravstvenog osiguranja svojih zaposlenika. U tom 
slučaju, tvrtka ugovara plan zdravstvenog osiguranja s trećom stranom. 
„Samoosiguravajuće“ tvrtke najčešće su velika poduzeća, kao na primjer 
General Motors.  
o Financiranje: Osiguranje pod pokroviteljstvom poslodavca financira se od strane 
poslodavca (koji obično plaća većinu premije) te radnika (koji plaća ostatak premije). 
2005. godine godišnja privatna premija osiguranja pod pokroviteljstvom poslodavca 
iznosila je u prosjeku 4,024 dolara za jednu osobu te 10,880 dolara za četveročlanu 
obitelj.  
o Prednosti: Prednosti se uvelike razlikuju unutar odreĎenih vrsta planova 
zdravstvenog osiguranja. Neki planovi pokrivaju lijekove na recept, a neki ne. Stupanj 
podjele troškova (odreĎen iznos kojeg zajednički pokrivaju poslodavac i zaposlenik te 
iznos osiguranja koje plaća osiguranik) znatno se razlikuje ovisno o vrsti plana. 
• Privatno negrupirano osiguranje (pojedinačno trţište) 
o Osnove: Pojedinačno trţište obuhvaća umirovljen dio stanovništva te samozaposlene 
pojedince. Osim toga, ono obuhvaća pojedince koji nisu u mogućnosti dobiti 
osiguranje od strane poslodavca. Za razliku od grupnog trţišta (osiguranje pod 
pokroviteljstvom poslodavca), pojedinačno trţište omogućuje osiguravajućim 
društvima uskraćivanje prava na osiguranje na temelju postojećih uvjeta.  
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o Administracija: Planovi osiguranja upravljani su od strane privatnih osiguravajućih 
društva.  
o Financiranje: U svrhu pokrivanja troškova osiguranja, pojedinci samostalno plaćaju 
premije. Rizik ovakve vrste osiguranja ovisi isključivo o zdravstvenom stanju 
pojedinca, za razliku od grupnog trţišta u kojem se rizik proteţe izmeĎu više 
pojedinaca. Kao takvo, ovo nisko rizično osiguranje omogućuje zdravim pojedincima 
plaćanje niske premije, dok za bolesne pojedince visokog rizika vrijedi suprotno. 
o Prednosti: Prednosti se uvelike razlikuju unutar odreĎenih vrsta planova osiguranja. 
FINANCIRANJE ZDRAVSTVENOG SUSTAVA SAD-a 
Financiranje zdravstvenog sustava centrirano je oko priljeva novca iz dva smjera, prikupljanje 
novčanih sredstava za zdravstvenu skrb (priljev novčanih sredstava) te naknada za 
zdravstvenu skrb od strane davatelja zdravstvenih usluga (odljev novčanih sredstava). U 
Sjedinjenim Američkim Drţavama odgovornost za te dvije funkcije podijeljena je izmeĎu 
privatnih osiguravajućih društva i Vlade, te su sukladno tome obje strane u političkom 
kontekstu poznate kao „obveznici“. Kao takve, Sjedinjene Američke Drţave smatraju se 
sustavom „višestrukog plaćanja“.  
• Pojedinci te tvrtke 
o Porezi: Fizičke osobe i tvrtke Vladi plaćaju porez na dohodak. Osim toga, postoji i 
takozvani porez na isplatne liste za poslodavce i zaposlenike pomoću kojeg se 
financira program Medicare.  
o Premije: Tvrtke plaćaju sve ili većinu premija za osiguranje zaposlenika pod 
pokroviteljstvom poslodavca dok zaposlenici plaćaju ostatak. Na pojedinačnom 
trţištu, pojedinci sve premije plaćaju samostalno. Premije za osiguranje pod 
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pokroviteljstvom poslodavca te premije za pojedinačna osiguranja prikupljaju privatni 
osiguravatelji.  
o Izravno plaćanje ili plaćanje „iz vlastitog džepa“: Ovaj način plaćanja je zapravo 
izravno plaćanje davatelju usluge za pruţanje zdravstvene skrbi (na primjer: 
participacije).  
• Vlada 
o Medicare, Medicaid, S-CHIP te VA programi: Novcem prikupljenim kroz poreze 
Vlada nadoknaĎuje troškove davatelja usluga koji brinu o pacijentima upisanima u navedene 
programe.  
 o Premije javnih službenika: Vlada takoĎer koristi novce prikupljene kroz poreze 
kako bi podmirili troškove zdravstvenog osiguranja za savezne zaposlenike te ostale 
djelatnike javnih sluţbi. 
o Porezna subvencija: Postoji porezna subvencija za osiguranje pod pokroviteljstvom 
poslodavca ( nije prikazano na grafikonu) koja predstavlja veliki izdatak za Vladu 
(pribliţno 100 milijardi dolara). Zaposlenici primaju porezne olakšice kao naknadu za 
zdravstveno osiguranje te zbog toga poslodavci mogu troškove zdravstvenog 
osiguranja pripisati troškovima poslovanja. [Budući da se poslodavce oporezuje samo 
na profit, to jest primanja koja iznose više od troškova poslovanja, u mogućnosti su 






• Privatni osiguravatelji  
o Privatni osiguravatelji prihvaćaju premije od strane pojedinaca, trvtki te Vlade, dok 
zauzvrat davateljima zdravstvenih usluga nadoknaĎuju troškove zdravstvene skrbi 
pacijenata. 
• Davatelji zdravstvenih usluga 
o Davatelji zdravstvenih usluga (liječnici, srodni zdravstveni djelatnici, bolnice i druge 
zdravstvene ustanove) brinu o pojedincima. Naknadu za svoje usluge primaju od 
strane privatnih osiguravatelja te Vlade.  
Drţavnim rashodima 2002. godine pokriveno je 44.9% troškova zdravstva u 
Sjedinjenim Američkim Drţavama, dok je preostalih 55.1% pokriveno od strane 
privatnih korisnika. Sjedinjene Američke Drţave 2003. godine potrošile su 1.7 bilijuna 
dolara na zdravstvene izdatke.  Od te svote novaca, većina je uloţena u bolničku skrb 
te kliničke i liječničke usluge.  
 
ZDRAVSTVENI SUSTAV SAD-a U INTERNACIONALNOM KONTEKSTU 
 [Napomena: Ovaj dio preuzet je direktno iz članka „OECD Health Data 2005: How Does the 
United States Compare” (op.prev. naziv članka)]. 
Zdravstveni troškovi i financiranje 
Sjedinjene Američke Drţave 2003. godine utrošile su 15% BDP-a na zdravstvenu skrb, što 
čini najveći postotak u zemljama OECD-a (organizacija razvijenih zemalja). U zemljama 
OECD-a prosječni postotak BDP-a utrošenog na zdravstvenu skrb iznosi 8.6%. Sjedinjene 
Američke Drţave takoĎer troše više na zdravstvenu skrb po stanovniku negoli bilo koja druga 
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zemlja OECD-a. Ukupna zdravstvena potrošnja po stanovniku 2003. godine iznosila je 5,635 
američkih dolara ( prilagoĎeno paritetu kupovne moći), čak dvostruko više od OECD prosjeka 
koji iznosi 2,307 američkih dolara.  
IzmeĎu 1998. i 2003. godine izdaci za zdravstvenu skrb po stanovniku u Sjedinjenim 
Američkim Drţavama u realnim uvjetima porasli su u prosjeku za 4.6% godišnje te je ta stopa 
rasta usporediva s OECD prosjekom koji iznosi 4.5% godišnje.  
Javni sektor glavni je izvor financiranja zdravstva u svim OECD zemljama, izuzevši 
Sjedinjene Američke Drţave, Meksiko te Koreju. U Sjedinjenim Američkim Drţavama 44% 
zdravstvenih troškova financira se putem vladinih prihoda, što je znatno ispod prosjeka 
zemalja OECD-a koji iznosi 72%. U Sjedinjenim Američkim Drţavama privatno osiguranje 
iznosi 37% ukupne zdravstvene potrošnje, što je daleko najveći udio meĎu zemljama OECD-
a. Kanada, Francuska i Nizozemska takoĎer imaju razmjerno velik udio financiranja od strane 
privatnih osiguravatelja (više od 10%).  
Ljudski te fizički resursi u sektoru zdravstva  
• Sjedinjene Američke Drţave 2002. godine imale su 2.3 uvjeţbana liječnika na 1000 
stanovnika, što je ispod OECD prosjeka koji iznosi 2.9 na 1000 stanovnika. 
• U Sjedinjenim Američkim Drţavama 2002. godine bilo je 7.9 medicinskih sestara na 
1000 stanovnika, što je ispod OECD prosjeka koji iznosi 8.2 medicinskih sestara na 
1000 stanovnika.   
• Broj kreveta za bolesnike s akutnim sindromima u bolnicama Sjedinjenih Američkih 
Drţava 2003. godine iznosio je 2.8 na 1000 stanovnika, što je ispod prosjeka OECD-a 




Zdravstveni status te faktori rizika 
Većina zemalja OECD-a doţivjela je veliki napredak u produljenju očekivanog trajanja ţivota 
u proteklih 40 godina. U Sjedinjenim Američkim Drţavama očekivano trajanje ţivota pri 
roĎenju uvećalo se za 7.3 od 1960. do 2002. godine, što je manje od uvećanja očekivanog 
trajanja ţivota u Japanu (14 godina) ili povećanja od 8.4 godina u Kanadi. Očekivano trajanje 
ţivota u SAD-u 2002./2003. godine iznosilo je 77.2 godine, što je ispod OECD prosjeka koji 
iznosi 77.8 godina. Japan, Island, Španjolska, Švicarska i Australija svrstavaju se u prvih 5 
zemalja koje su evidentirale najduţi ţivotni vijek meĎu zemljama OECD-a. 
U nekoliko posljednjih desetljeća smrtnost dojenčadi u SAD-u pala je u velikoj mjeri, ali opet 
ne toliko koliko u većini drugih zemalja OECD-a. U 2002. godini stopa smrtnosti dojenčadi u 
SAD-u bila je 7 umrlih na 1000 ţivoroĎene djece, što je iznad OECD prosjeka koji iznosi 6.1. 
MeĎu zemljama OECD-a stopa smrtnosti dojenčadi najniţa je u Japanu i nordijskim 
zemljama (Islandu, Švedskoj, Finskoj i Norveškoj). U navedenim zemljama stopa smrtnosti 
dojenčadi iznosi 3.5 umrlih na 1000 ţivoroĎene djece. 
U Sjedinjenim Američkim Drţavama udio pušača meĎu odraslima od 1980. do 2003. godine 
pao je s 33.5% na 17.5%, te uz Kanadu i Švedsku spada u zemlje OECD-a s najniţom stopom 
pušača. Stopa pretilosti kod odraslih osoba (30.6%, 2002. godine) jedna je od najviših u 
zemljama OECD-a, nakon čega slijedi Meksiko (24.2%, 2000. godine) te Velika Britanija 







3.2. COMMENTARY AND ANALYSIS 
 
SOURCE TEXT II: Overview of the U.S. Health Care System 
Genre: Health care overview; medical article; life/health article 
Source: American Medical Student Association 
Reference: Chua, K.P. (2006). Overview of the U.S. Health Care System. American 
Medical Student Association 
Audience: The text is written to an unknown audience and it is intended to be read by general 
population. The author assumes that the reader´s knowledge about this topic is not so 
extensive and that is why he is trying to explain how the system works in the simplest 
possible way. 
Purpose of writing: The aim of this text is to summarise all the basic facts about the U.S. 
health care system. The author wants to deliver the most important information about the 
topic to the reader. There is an ongoing debate about the U.S. health care system and the 
author thinks that the reader needs to understand the structure of the system in order to 
understand the debate.   
Authenticity: Due to the fact that the source of the text is American Medical Student 
Association and that the article is written by the attending physician in the Division of 
Emergency Medicine at Boston Children's, who graduated from Vanderbilt University with a 
B.S. in Neuroscience and received an M.D. from Washington University School of Medicine 
in St. Louis (Harvard University, 2016), we can consider this article authentic.  
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Style: Writing style of this text can be considered as expository. The author uses a lot of 
supportive details, facts and examples. Voice of the text is objective because the author did 
not include his view on the subject. The author tries to familiarise the reader with the topic by 
describing the system and that is why we can say that this is a descriptive article as well.  
Level of formality: Formal (academic writing; writing follows all the accepted language 
principles; no colloquial expressions; appropriate for academic setting) 
Layout: The text is divided into four main parts. Four main titles are written in bold letters 
and capitalised, while the subtitles are also written in bold letters but without capitalisation. In 
the first part the author introduces the reader with the subject. The second part is divided into 
two sections, public and private health insurance. Those two subtitles are written in Italics. 
The text in every section is written as a bulleted list. Due to this way of writing, it is easier for 
the reader to notice the most important facts and figures because the sentences are quite short 
and not to complex. The third part is also written as a bulleted list. The fourth part is divided 
into three sections. In this part the author did not use the bulleted list. At the end of the article 
there is no conclusion, just a reference list. Throughout the text, the author used bold letters 
for some terms, trying to draw the reader´s attention to them.  
Content: In the introduction part the author explains what the purpose of this overview is. 
Since there is an ongoing debate about the U.S. health care system, the author´s aim is to 
provide basic information about it. The author believes that the first step towards 
understanding this polarasing debate is to learn the basic facts about the system in general. 
The body of the overview is divided into three parts. The first part of the body is focused on 
the organisation of the U.S. health care system. The author explains the two branches of the 
system, public and private health insurances. Public health insurance is divided into three 
main parts, Medicare, Medicaid and other public systems. On the other hand, private health 
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insurance is divided into two parts, employer-sponsored insurance and private non-group 
insurance. The second part of the body deals with financing of the system. In this part the 
author analyses U.S. health care system as a”multi-payer” system. According to the author, 
the financing of the system is divided among individuals, businesses, the government, private 
insurers and health service providers. The last part of the body focuses on comparing the U.S. 
health care system with health services of the other countries. This comparison is based on 
three different aspects: financing, human and physical resources and health status and risk 
factors. This last part of the body is also the last part of the overall overview.  
Cohesion: Throughout the whole overview the author is dealing with the same topic and 
accordingly he uses the same terminology from the start to the end. Due to this repetition of 
the same terms, the author achieves a good integration of the text. This entire overview is 
focused on just one topic, U.S. health care system, and in every section the author deals with 
different aspects of that topic.   
Sentence patterns: The author uses rather short and simple sentences due to the fact that this 
overview is written for a general population. His usage of appropriate vocabulary, correctly 
used punctuation, no jargon or cliches, etc., is suitable for this kind of a formal text. When he 
is reporting facts and figures taken from the research conducted in the last few years, the 
author uses past tense. On the other hand, when the author is reporting about the basic 
principles of the system, he uses present simple since these principles are considered as 
general actions/situations that do not change over time.   
Terminology of the subject: In this overview the author is combining the terminology 
connected with health services, financing, taxes, insurances, demography, etc. Since this text 
is not based on just one aspect of the health care system, it is necessary to use terminology of 
different fields. All the terms used in this text are closely related to the different aspects of the 
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main topic. For example, the author uses terms such as “infant mortality rate“ (demography), 
“government revenues“ (financing), “payroll tax“ (taxes), “acute care hospital beds” (health 
care system), etc.  
 
The most considerable difficulties while translating this overview were the names of the 
programmes. Since the topic of the text is U.S. health care system, some of the names do not 
have the corresponding translation in the target language (due to the fact they do not exist in 
the target language community). For example, “The State Children’s Health Insurance 
Program” does not exist in the Croatia. The most similar thing is “Program zdravstvene 
zaštite djece, higijene i pravilne prehrane djece u dječjim vrtićima”, but since this program is 
designed only for children enrolled in early childhood education, we cannot use this term 
because it does not fit into the context of the original text. The same situation is with “The 
Veteran’s Administration” program. I solved this problem using the original names in the 
translation, explaining the reason for that by writing the translator´s remark in brackets.  
Another issue was the translation of the term “AMSA Jack Rutledge Fellow 2005-2006“. 
Since this term is referring to the scholarship program for U.S. students, there is no equivalent 
term in the target language.  
 
While translating some of the terms, it was necessary to use descriptive translation due to the 
fact there is no equivalent term in the target language. For example, the term „acute care 
hospital beds“ could be translated as “akutni kreveti”, but this translation is not in the tone of 
the target language. I found some articles in which the authors use this translation of the term, 
but they put it under the quotation marks. Since this is a formal text I have decided to use a 
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descriptive phrase instead (“broj kreveta za bolesnike s akutnim sindromima“). I consider that 
this translation is more appropriate since the word “acute“ refers to the patients, not beds.  
 
Another issue I came across while translating was when the term of the source language has 
several synonyms in the target language. For example, the term “life expectancy“ can be 
translated as “očekivani ţivotni vijek”, “očekivano trajanje ţivota”, “prosječan ţivotni vijek”, 
etc. In order to use the most appropriate term, I checked various demographic reports. The 
official term which is used in this kind of reports is “očekivano trajanje ţivota” so I used the 
same term in my translation. The term “infant mortality rate” also has several synonyms when 
it comes to the target language. In the first version of the translation I used the term “stopa 
smrtnosti novoroĎenčadi” but after checking various demographic reports, I found out that the 
official term which is used is “stopa smrtnosti dojenčadi”.  
 
Sometimes when we are translating from the source language into the target language, it is 
necessary to improvise in order to keep the meaning of the original phrase. In English 
language there is a wide range of compound nouns which do not have the equivalent terms in 
the Croatian language. For example, if we want to translate the term “employer-sponsored 
insurance”, we need to use a descriptive phrase. One possible translation is “osiguranje od 
strane poslodavca” but more appropriate translation (the one which is used in the official 
documents) is “osiguranje pod pokroviteljstvom poslodavca”.  
 
Another example of a compound noun which was quite tricky to translate is “self-insured 
companies”. Even the author used quotation marks for this term in the original text. 
Apparently the usage of this term is not so often in the source language as well. One possible 
translation of the term is “tvrtke koje samostalno pokrivaju zdravstveno osiguranje”, but since 
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the translation should be clear and concise, I decided to use the term “samosiguravajuće 
tvrtke” (putting it under the quotation marks). The reader can conclude what is meant under 
this term from the surrounding text because the real meaning of the term is explained in the 
next sentence.  
 
While translating, the translator needs to avoid ambiguity. For example, while translating the 
sentence “states must cover very poor pregnant women, children, elderly...“, translator needs 
to be very careful. If the translator uses the adjective “poor“ at the wrong part of the sentence, 
the meaning of the original sentence is lost. Literal translation of the sentence would be 
“drţave moraju pokrivati osiguranje za siromašne trudnice, djecu, starije...“. This translation 
is not valid because the adjective “poor“ refers only to pregnant women, but in the original 
sentence it refers to the children and elderly as well. In order to avoid this issue, I did not use 
the literal translation of the adjective “poor“. Instead of the term “siromašan“ I used a phrase 
“osobe slabijeg imovinskog statusa” and in the next part of the sentence I listed all the 
individuals who belong to this group. The final translation was “drţave moraju pokrivati 
osiguranje za osobe slabijeg imovinskog statusa, što uključuje trudnice, djecu, starije...“. 
 
When translating from English into Croatian language, we need to be careful when it comes 
to capitalisation. For example, when the names of non-profit organisations such as Blue Cross 
and Blue Shield are used in the source language every word is capitalised. But when it comes 
to the target language, only the first word is capitalised (Plavi kriţ; Plavi štit).  
 
Another difficulty connected with capitalisation was the translation of the word government. 
In the source language there is no capitalisation of the word, but in the target language there is 
a different set of rules. Names of institutions, organizations and associations should be written 
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with a capital letter. The term “federal government” is easy to translate because there is no 
capitalisation (the same is in Croatian language, for example “hrvatska vlada”). But when the 
author uses only the term “government”, it is questionable whether to use the initial 
capitalisation or not. According to the rules of the target language, the term government can 
be spelled with or without the initial capital letter. Since this is a formal text, I decided to use 
an initial capital letter because in the official documents of the target language, in the most 
cases, there is an initial capitalisation of the term. 
 
Since the sentence pattern of this text are rather short and not to complex, there was no need 
to separate them when translating. In order to adapt the translation to the target language, I 
used inversion when it was necessary. For example, when translating the sentence “Infant 
mortality rates in the United States have fallen greatly over the past few decades...“, in the 
translation I put the time phrase at the beginning of the sentence in order to adjust the 
translation to the tone of the target language (“U nekoliko posljednjih desetljeća stopa 











4. SOURCE TEXT III:  
 
BEING THE FIRST MAN ON THE MOON 
This story originally aired on Nov. 6, 2005. 
On July 20, 1969, Neil Armstrong stepped out of an odd-looking spaceship and into the pages 
of history as the first man on the moon. 
Today, he remains one of the most famous people on the planet, but he is also famously 
private. For years, Armstrong has shunned the media and the limelight, but last fall he took a 
giant leap back into the public view. He has finally authorized a biography, entitled First Man 
and written by James Hansen. 
In November, he agreed for the first time to a television profile, speaking to 60 Minutes 
correspondent Ed Bradley about his extraordinary life.  
Neil Armstrong still remembers the powerful liftoff of Apollo 11. "It felt like a train on a bad 
railroad track, shaking in every direction. And it was loud, really loud." 
Armstrong is 75 now, an aging hero, but his winning smile is still there. We remember him as 
the cool, confident commander of Apollo 11, joined by his crewmates, Buzz Aldrin and 
Michael Collins. On a windswept day, Bradley went with Armstrong to an old Apollo launch 
pad at Kennedy Space Center to hear the story of one of man's greatest adventures. 
 
"That July morning in 1969, when you came out and you gave that thumbs-up, I mean, that 




"Yeah, but a little bit of a sham, I admit," says Armstrong. "You know, the reality is, a lot of 
times you get up and get in the cockpit, and something goes wrong somewhere and you go 
back down. So, actually, when you actually lift off, it's really a big surprise." 
 
Perched atop a Saturn 5 rocket, the astronauts were on their way to meet the challenge 
President Kennedy had made eight years earlier: to land a man on the moon and return him 
safely to earth before the end of the decade. 
It took 400,000 workers and $24 billion, intended in large part to prove American superiority 
over the Soviets. Armstrong acknowledges that the hopes of the nation were riding on the 
mission. "We wanted to do well. And, even more than that, you hope that you don't, you as a 
person, don't make any mistakes." And he didn't. Armstrong's entire life had prepared him 
well, starting with a childhood fascination with flight. He earned his pilots license at 16 before 
he learned to drive. By age 21, he was flying combat missions over Korea. After the war, he 
became a hotshot test pilot, flying the famous X-15 at 4,000 miles an hour to the edge of the 
atmosphere. It was during that time, in 1962, when he faced his most difficult test, losing his 
2-year old daughter, Karen, to brain cancer. Armstrong poured himself into his work. "I 
thought the best thing for me to do in that situation was to continue with my work, keep 
things as normal as I could. And try as hard as I could not to have it affect my ability to do 
useful things." 
 
"But that's not an easy thing to do. How do you think you did?" Bradley says.  
 





During that same difficult year, Armstrong was chosen to be an astronaut. He flew his first 
space mission in 1966 on Gemini 8, and nearly lost his life when his tiny capsule briefly spun 
out of control.  
 
He cheated death again two years later, while flying an experimental device designed to 
simulate a lunar landing. When it malfunctioned, Armstrong was sitting at the controls. He 
ejected barely 100 feet from the ground. 
 
After the almost-fatal ordeal, Armstrong went back to his office to do some paperwork. "I did. 
There was work to be done," says Armstrong, matter-of-factly. 
 
"Wait a minute. You were just almost killed," Bradley says.  
 
"Well, but I wasn't," says Armstrong. 
 
Armstrong stood out, even among a class of astronauts that had the right stuff. His depth of 
experience and nerves of steel earned him, at age 38, the command of Apollo 11. The trip to 
the moon took four days; after achieving lunar orbit, Michael Collins would remain in the 
command module, while Neil Armstrong and Buzz Aldrin climbed into the lunar module, 
undocked, and began their descent.  
But the landing took an unexpected turn: the onboard guidance system was sending 
Armstrong and Aldrin right towards disaster. 
"Our autopilot was taking us into a very large crater, about the size of a big football stadium 
with steep slopes on the crater, covered with very large rocks about the size of automobiles. 
That was not the kind of place I wanted to try to make the first landing," Armstrong says. 
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Armstrong overrode the autopilot and looked for a safe place to land, but the detour cost them 
precious fuel, and they were about to run out.  
A worldwide television audience of a nearly a billion people was on the edge of their seats 
and so was CBS' own Walter Cronkite. 60 Minutes couldn't resist reuniting the former 
anchorman with the former spaceman. There are things they can laugh about now but, at the 
time, those final seconds were almost unbearable. 
"We were following the flight plan and we suddenly realized that he had made a detour and 
we didn't know how long that detour was going to be," remembers Cronkite. "Yes, I was very 
much concerned. I think all of us who were following the flight that closely were scared to 
death. If he wasn't, we were."  
Then came Armstrong's famous words: "Houston, Tranquility Base here. The eagle has 
landed." 
"Roger, Tranquility, we copy you on the ground, you got a bunch of guys about to turn blue. 
We're breathing again. Thanks a lot," mission control replied. 
The landing left Cronkite almost speechless.  
"You are a man who I've known for years never to be at a loss for words but you were at a 
loss for words then. I think all you could come up with was, 'Oh, boy,' " says Bradley. 
 
"It turned out I didn't have anything to say at all except, 'Wow, oh, boy. Oh, boy,' " Cronkite 
says, laughing. "Perfectly speechless." 
The ghostly image of man on the moon was beyond words. Armstrong paused on the bottom 
rung of the ladder and planted his left boot on the lunar dust. 
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"That's one small step for man, one giant leap for mankind," Armstrong said as he set foot on 
the moon. 
"Do you recall how you came up with that 'A small step for man?' What was the inspiration 
for it?" Bradley asks.  
"I thought, 'Well, when I step off, I just gonna be a little step.' … But then I thought about all 
those 400,000 people that had given me the opportunity to make that step and thought 'It's 
going to be a big something for all those folks and, indeed, a lot of others that even weren't 
even involved in the project.' So it was a kind of simple correlation of thoughts," Armstrong 
says. 
 
Armstrong clearly remembers the lunar surface. "It's a brilliant surface in that sunlight. The 
horizon seems quite close to you because the curvature is so much more pronounced than here 
on earth. It's an interesting place to be. I recommend it." 
Armstrong and Aldrin spent just a short time on the lunar surface, testing the gravity, 
completing a long list of experiments, and marking their journey. They had come in peace for 
all mankind, but stayed less than a day. 
The hard part was re-entry. But when they returned to earth, they were superstars. In New 
York, four million people showered them with ticker tape. On a 45-day victory lap around the 
world, they were met by crowds in the Congo and by the queen at Buckingham Palace.  
 
But as Armstrong reveals in his new biography, published by CBS sister company Simon & 





"Friends and colleagues all of a sudden looked at us, treated us slightly differently than they 
had months or years before when we were working together. I never quite understood that," 
Armstrong  says.  
"You said once to a reporter, 'How long must it take before I cease to be known as the space 
man?' Why did you make that comment?" Bradley says.  
"I guess we all like to be recognized not for one piece of fireworks, but for the ledger of our 
daily work," Armstrong says. 
Strolling around the Ohio farm where he was born, Armstrong is easy to talk to, but hard to 
know. He can seem guarded, but above all we were struck by his humility.  
"You sometimes seem uncomfortable with your celebrity. That you would rather not have all 
of this attention," Bradley says. 
"No, I just don't deserve it," Armstrong says, laughing. 
"But look. How many people have walked on the moon? Twelve? You were the first. You 
were chosen to do that. That's special," says Bradley. 
"Yeah, I wasn't chosen to be first. I was just chosen to command that flight. Circumstance put 
me in that particular role. That wasn't planned by anyone," Armstrong says.  
 
After Apollo 11, Armstrong hung up his spacesuit, and never felt the need for an encore. For 
eight years, he taught engineering at the University of Cincinnati, surely the students' only 
professor who had walked on the moon.  
"In the midst all your professional achievements, you've managed to get married, to have a 




"The one thing I regret was that my work required an enormous amount of my time, and a lot 
of travel," Armstrong says. "And I didn't get to spend the time I would have liked with my 
family as they were growing up." 
Armstrong has two sons with his wife of 38 years, Janet, who divorced him in 1994. 
 
He remarried several years ago. In the autumn of his life, he lives very much in the present, 
refusing to let his famous deed define him. He has made a comfortable living serving on 
corporate boards, but even in retirement he keeps a watchful eye on the space program. He 
would like to see it restored to its glory days. 
Armstrong knew the Apollo program had a limited life but expected it to last longer. "I fully 
expected that, by the end of the century, we would have achieved substantially more than we 
actually did." 
"And why do you think we didn't continue?" Bradley says.  
"When we lost the competition, we lost the public will to continue," Armstrong replies.  
The man who once rode a 160-million horsepower rocket now flies a glider, a plane with no 
engine. 
"Gliders, sail planes, they're wonderful flying machines. It's the closet you can come to being 
a bird," says Armstrong. 
What does Armstrong get out of gliding? "Oh, it is self satisfaction. A sense of 




NASA recently announced plans to send men back to the moon by 2018 and later to Mars. 
Don't think Neil Armstrong hasn't noticed. 
"You said you would like to see us go back to the moon, and then go on to Mars. Something 
you want to do at this point in your life?" Bradley asks.  
"I don't think I'm going to get the chance. But I don't want to say I'm not available," 





















4.1. TRANSLATION OF THE SOURCE TEXT III: 
 
PRVI ČOVJEK NA MJESECU 
 
Ova priča izvorno je emitirana 6. studenog 2005. godine. 
20. srpnja 1969. godine Neil Armstrong izašao je iz neobične svemirske letjelice te ušao u 
povijest kao prvi čovjek na Mjesecu.  
Neil Armstrong ostao je sve do danas jedan od najslavnijih ljudi na svijetu, posebno poznat po 
tome da se nikada nije previše izlagao očima javnosti. Armstrong je godinama izbjegavao 
medijsku paţnju no prošle jeseni napravio je veliki korak te se otvorio javnosti.  Konačno je 
odobrio vlastitu biografiju pod nazivom Prvi čovjek autora Jamesa Hansena.  
U studenom je po prvi puta pristao na televizijski intervju, pričajući o svojem izvanrednom 
ţivotu s dopisnikom emisije 60 Minutes, Edom Bradleyem.  
Neil Armstrong i dalje pamti spektakularno polijetanje Apolla 11. „Osjećao sam se kao da 
sam u vlaku koji se kreće po lošoj pruzi, sve je podrhtavalo. Bilo je glasno, izrazito glasno.“ 
Danas ovaj ostarjeli junak ima 75 godina no njegov privlačan osmjeh još uvijek je na 
njegovom licu. Uz ostale članove posade, Buzza Aldrina te Michaela Collinsa, Armstronga 
pamtimo kao staloţenog, uvjerenog zapovjednika Apolla 11. Tog vjetrovitog dana, Bradley je 
otišao s Armstrongom do svemirskog centra „Kennedy“, gdje se nalazi stara lansirna rampa 
Apolla, kako bi čuo priču o jednoj od čovjekovih najvećih avantura.  
 
„Smatram kako je tvoj nastup bio veoma samouvjeren kada si tog srpanjskog jutra 1969. 




„Da, ali moram priznati kako je ta gesta zapravo bila varka“, rekao je Armstrong. „Znaš, 
stvarnost je kada se pojaviš, uĎeš u pilotsku kabinu i nešto poĎe po zlu pa se moraš vratiti. 
Tako da kada zaista uzletiš, sve predstavlja jedno veliko iznenaĎenje.“ 
 
Smješteni na vrhu rakete Saturn 5, astronauti su bili na putu da ispune izazov kojeg je 
predsjednik Kennedy najavio osam godina ranije, spustiti čovjeka na Mjesec te ga sigurno 
vratiti na Zemlju prije kraja desetljeća. Bilo je potrebno 400 000 radnika te 24 milijarde 
dolara, velikim dijelom namijenjenih kako bi se dokazala američka nadmoć na Sovjetskim 
Savezom. Armstrong priznaje kako je nacija polagala sve nade u ovu misiju. „Ţeljeli smo 
uspjeti. No još više od toga, nadaš se da ti kao pojedinac nećeš napraviti neku pogrešku.“ I 
Armstrong nije pogriješio. Njegov cijeli ţivot bio mu je dobra priprema, počevši od 
očaranosti letom još od djetinjstva. Pilotsku dozvolu stekao je sa 16 godina, prije negoli je 
naučio voziti. Do svoje 21 godine, letio je u borbenim misijama u Koreji. Nakon rata, postao 
je uspješan testni pilot, leteći poznatim raketnim zrakoplovom X-15 sve do ruba atmosfere, 
brzinom od 4000 milja na sat.  U to vrijeme, 1962. godine, našao se pred najteţim ispitom, 
izgubivši 2-godišnju kćer, Karen, nakon borbe s tumorom na mozgu. Nakon toga Armstrong 
se posvetio poslu. „Smatrao sam da je najbolje za mene u toj situaciji samo nastaviti s radom, 
drţeći stvari u normali. Trudio sam se najviše koliko sam mogao da to ne utječe na moju 
sposobnost obavljanja korisnih stvari.“ 
 
„Ali to nije tako lako učiniti. Što misliš kako si uspio?“, pitao je Bradley.  
 
„U to vrijeme mislio sam da se moja obitelj dobro nosi s tim i ja sam činio sve što je u mojoj 




Tijekom te iste teške godine, Armstrong je odabran za astronauta. Njegova prva misija u 
svemiru bila je 1966. godine letjelicom Gemini 8, kada je skoro izgubio ţivot uslijed kratke 
nekontrolirane vrtnje male kapsule u kojoj se nalazio.  
 
Dvije godine kasnije, dok je letio na eksperimentalnoj napravi konstruiranoj za simulaciju 
slijetanja na Mjesec, Armstrong je opet prevario smrt. Upravljao je letjelicom kada je 
uslijedio kvar te se jedva uspio izbaciti 30 metara iznad tla. 
 
Nakon bliskog susreta sa smrću, Armstrong se vratio rješavanju papirologije. „Posao se 
morao obaviti“, hladnokrvno je rekao Armstrong. 
 
„Samo trenutak. Skoro si poginuo,“ rekao je Bradley. 
 
„Da, ali nisam,“ reče Armstrong.  
 
Armstrong se isticao čak i meĎu najboljim kolegama astronautima. U 38. godini svojim 
iznimnim iskustvom i čeličnim ţivcima zasluţio je upravljanje Apollom 11. Put do Mjeseca 
trajao je četiri dana. Nakon ulaska u mjesečevu orbitu, Michael Collins je ostao u 
upravljačkom modulu, dok su se Neil Armstrong i Buzz Aldrin popeli u usidreni lunarni 
modul te započeli spuštanje na Mjesec. 
No uslijed slijetanja dogodio se neočekivani obrat, ugraĎen sustav za navoĎenje slao je 
Armstronga i Aldrina ravno u propast. 
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„Autopilot nas je vodio u veliki krater strmih padina veličine prostranog nogometnog stadiona 
koji je bio prekriven golemim kamenjem veličine automobila. To nije bilo mjesto za pokušaj 
prvog slijetanja,” rekao je Armstrong.  
Armstrong je isključio autopilot te se bacio u potragu sigurnog mjesta za slijetanje, no to  
skretanje s puta ih je stajalo dragocjenog goriva koje je ionako bilo pri kraju.  
Ljudi ispred malih ekrana diljem cijelog svijeta, kao i CBS-ov voditelj Walter Cronkite, 
nervozno su pratili što se dogaĎa. Voditelji Emisije 60 Minutes nisu mogli odoljeti ţelji da 
ponovno spoje tadašnjeg urednika vijesti s nekadašnjim astronautom. Postoje stvari kojima se 
sada mogu smijati, ali onda su te posljednje sekunde bile gotovo nepodnošljive.  
„Slijedili smo plan puta no odjedanput smo shvatili kako smo skrenuli s rute i nismo znali 
koliko će taj obilazak trajati“, prisjeća se Cronkite. „Da, bio sam jako zabrinut. Mislim da smo 
svi mi koji smo izbliza pratili let bili preplašeni na smrt. Ako on nije bio, mi jesmo.“ 
Onda su uslijedile Armstrongove slavne riječi: „Houston, ovdje Baza tišine. Orao je sletio.“  
„Sve je u redu, Baza, primili smo na znanje da ste na tlu. Ovdje se nalazi puno ljudi koji su 
ostali bez daha. Ponovno moţemo normalno disati. Hvala puno,“ odgovorila je misija 
kontrole.  
Slijetanje je Cronkitea ostavilo bez riječi. 
„Ti si čovjek kojeg poznajem godinama i koji nikada ne ostane bez teksta no tog 
trenutka si zanijemio. Mislim da su jedine riječi koje si uspio izgovoriti bile „O 
čovječe“,“ rekao je Bradley.  
„Ispalo je da nisam imao ništa drugo za reći osim „O čovječe. O čovječe,“  rekao je Cronkite 
smijući se. „Zanijemio sam.“ 
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Ta sablasna slika čovjeka na Mjesecu bila je neopisiva riječima. Armstrong je zastao na 
posljednjoj prečki ljestvi te je lijevom čizmom stao na mjesečevu prašinu.  
„Ovo je mali korak za čovjeka, ali veliki za čovječanstvo,“ rekao je Armstrong nakon što je 
spustio nogu na mjesečevu površinu.  
„Sjećaš li se kako si se dosjetio izreke „Ovo je mali korak za čovjeka“? Odakle ti inspiracija 
za to?“ pitao ga je Bradley.  
„Razmišljao sam o tome kada siĎem kako će to biti samo mali korak... No onda sam se sjetio 
onih 400 000 ljudi koji su mi dali priliku da napravim taj korak i pomislio sam kako će to biti 
nešto veliko za sve te ljude i mnoge druge koji čak nisu ni bili uključeni u projekt. Tako da je 
to ustvari bilo jednostavno povezivanje misli,“ rekao je Armstrong. 
Armstrong se jasno sjeća površine Mjeseca. „Na toj sunčevoj svjetlosti Mjesec je jedna 
blistava površina. Čini se kao da je obzor sasvim blizu jer je zakrivljenost mnogo više 
naglašena nego na Zemlji. Zanimljivo mjesto za vidjeti, preporučujem.“ 
Testirajući gravitaciju, dovršavajući dug popis eksperimenata te obiljeţavajući svoje 
putovanje, Armstrong i Aldrin nisu proveli puno vremena na mjesečevoj površini. Došli su u 
miru u ime cijelog čovječanstva, a ostali su manje od jednog dana.  
Slijedio je teţi dio, povratak. No kada su se vratili na Zemlju, bili su zvijezde. U New 
Yorku ih je dočekalo četiri milijuna ljudi obasipajući ih ukrasnim trakama. Na 45. dan 
pobjedničkog kruga oko svijeta, susreli su se s mnoštvom ljudi iz Konga te s kraljicom 




U novoj biografiji koju je objavila sestrinska tvrtka CBS-a, Simon&Schuster, 
Armstrong otkriva kako nije bio spreman na svu tu iznenadnu slavu te kako smatra da 
je to s jedne strane blagoslov, a s druge strane teret.  
„Prijatelji i kolege odjednom više nisu jednako gledali na nas, odnosili su se prema nama 
drugačije negoli prije par mjeseci ili godina kada smo radili zajedno. Nikada nisam to 
razumio,“ rekao je Armstrong.  
„Jedanput ste rekli novinaru: „Koliko vremena treba proći prije nego prestanem biti poznat 
kao čovjek iz svemira?“. Čemu takav komentar?“, upitao ga je Bradley.  
„Mislim da mi svi nismo htjeli biti priznati za samo jedan mali dio obavljenog posla, već za 
sve ono što radimo svaki dan,“rekao je Armstrong.  
Šetajući po farmi u Ohiou gdje je Armstrong roĎen, bilo je lako voditi razgovor s njim, ali ga 
je bilo teško upoznati. Čini se kao rezervirana osoba, ali prije svega bili smo očarani 
njegovom poniznošću.  
„Ponekad se čini kao ti je neugodno zbog tvoje slave. Čini se kao da radije ne bi htio tu svu 
paţnju,“, rekao je Bradley. 
„Ne, samo je ne zasluţujem,“ rekao je Armstrong smijući se. 
 
„Ali gledaj to s ove strane, koliko ljudi je hodalo po Mjesecu? Dvanaest? Ti si bio prvi. Bio si 
odabran za tu ulogu. To je nešto posebno,“ rekao je Bradley.  
 
„Da, ali nisam bio odabran da budem prvi. Izabrali su me samo za upravljanje letom. Spletom 
okolnosti sam se našao u toj ulozi. Nitko to nije planirao,“ rekao je Armstrong.  
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Nakon Apolla 11, Armstrong više nije koristio svoje svemirsko odijelo te nikada nije osjetio 
potrebu za tim. Osam godina je poučavao strojarstvo na Sveučilištu u Cincinnatiju, gdje je 
sigurno bio jedini profesor koji je hodao po Mjesecu. 
„Uz sva profesionalna dostignuća, uspio si stupiti u brak te osnovati obitelj. Da li je bilo teško 
drţati ravnoteţu izmeĎu ta dva aspekta ţivota?“, upitao ga je Bradley.  
„Jedino zbog čega ţalim je to da moj rad zahtijeva ogromnu količinu vremena te puno 
putovanja,“ rekao je Armstrong. „I zbog toga nisam mogao provesti onoliko vremena koliko 
sam htio sa svojom obitelji i djecom kada su odrastali.“ 
Armstrong ima dva sina s bivšom 38-godišnjom ţenom Janet, od koje se razveo 1994. 
godine.  
Prije nekoliko godina ponovno se oţenio. U tom periodu svog ţivota, Armstrong se 
trudio ţivjeti u sadašnjosti ne dopuštajući da ga odreĎuju njegova poznata djela. 
Osigurao si je lagodan ţivot radeći u korporativnim odborima, no čak je i u mirovini 
pozorno pratio svemirske programe. Htio je doţivjeti povratak slavnih dana prošlosti.  
Armstrong je znao da Apollo program ima rok trajanja, ali je očekivao da će trajati duţe. 
„Iskreno sam mislio da ćemo do kraja stoljeća postići znatno više nego što zapravo jesmo.“ 
„Što misliš, koji je razlog zašto nismo nastavili s napretkom?“, pitao je Bradley.  
„Gubitkom konkurencije izgubili smo i volju javnosti za napretkom,“ odgovorio je 
Armstrong.  
Čovjek koji je nekada vozio raketu sa 160 milijuna konjskih snaga sada leti jedrilicom, 
avionom bez motora.  
„Jedrilice su izvanredni leteći strojevi. Pomoću njih čovjek moţe najbliţe osjetiti kako je to 
biti ptica,“ rekao je Armstrong.   
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Što Armstrongu predstavljaju jedrilice? „Ah, to je vrsta osobnog zadovoljstva. Osjećaj 
postignuća. Kad pokušavaš učiniti nešto bolje nego što misliš da moţeš,“ rekao je Armstrong.  
NASA je nedavno objavila kako planira poslati ljude na Mjesec do 2018. godine, a nešto 
kasnije i na Mars. Nemojte misliti da Neil Armstrong to nije primijetio.  
„Rekao si da ţeliš vidjeti kako se vraćamo na Mjesec, a nakon toga kako idemo na Mars. Da 
li je to nešto što bi ţelio učiniti u ovom trenutku svog ţivota?“, pitao je Bradley. 
 
„Nisam siguran hoću li dobiti priliku. Ali ne ţelim reći da nisam na raspolaganju,“ rekao je 
















4.2. COMMENTARY AND ANALYSIS 
Genre: An interview; (auto) biographical article 
Source: CBS News 
Reference: Schorn, D. (2005). Being the first man on the Moon. Retrieved from: 
http://www.cbsnews.com/news/being-the-first-man-on-the-moon/3/; on 4 May 2016 
Audience: Unknown audience; general population; the readers of the CBS News 
Purpose of writing: The aim of this interview is to share the specifics of Neil Armstrong´s 
life and his space adventure. Since Armstrong did not like to mix his private life and the 
public sphere, many people were interested into the details of his lifestyle. Through this 
interview, the public got a chance to meet real Armstrong and find out how is it like to travel 
in the space. Since Armstrong was the first man on the Moon, the audience got an insight into 
his first impressions while stepping on the Moon. Also, through this interview the public got 
all the information about his space adventure and the whole space experience.  
Authenticity: Since the interview is based on Armstrong’s confessions which the author 
gathered while talking with him, we can conclude that this interview is authentic.  
Style: The writing style of this text is descriptive, but narrative as well. Responding to the 
questions asked by his interlocutor, Armstrong is actually describing his life. What is more, 
various comments made by Armstrong´s interlocutor give us an insight into his lifestyle as 
well. This kind of subject-oriented writing style is suitable for the text like this. While reading 
this interview, the reader has a feeling like he or she is reading a story. This text is filled with 
details, jargon language, dialogues, comments and the tone is appropriate for such kind of 
writing. Writing style of this interview combines autobiographical and biographical details of 
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Armstrong´s life (combination of Armstrong´s responds on the given questions and 
commentary made by the author of the text). 
Level of formality: This is an informal text. Since the text is basically a conversation between 
two people, we can conclude that the level of formality is appropriate for this kind of personal 
and self-expressive extract. The text contains colloquial and slang expressions. Another 
element which shows us that the level of formality is not that high is the structure of the text 
(dialogues and comments). The author addresses Armstrong by using second person pronouns 
(you, your), which is another element of the informal text.  
Layout: Since this is an informal interview, the layout is quite unique. There is no standard 
question/answer interview structure. Instead, the whole text is a combination of short 
dialogues between Armstrong and his interlocutor and various remarks made by the author of 
the text. There is no introduction part, body or the conclusion. The whole text is a single unit.  
Content: This interview deals with details of Armstrong´s personal life and his space 
adventure. At the beginning of the interview, the author made a short introduction with only 
few sentences, where he described the importance of this great man. The dialogue between 
Armstrong and his interlocutor started immediately afterwards. The interlocutor did not ask 
typical interview questions. Instead, he shared his personal opinion and remarks regarding 
Armstrong´s life and space travel. Armstrong´s task in this interview was to comment the 
interlocutor’s words and ideas. At the beginning the conversation was focused on 
Armstrong´s space travel and Moon landing, and soon the subject changed swiftly towards 
Armstrong´s personal life. They tackled one particularly sad event from Armstrong´s life, the 
death of his 2-year old daughter. After that, the subject was again changed and they started 
talking about Armstrong´s outbreak as an astronaut. After a short analysis of his career, the 
subject changed again, this time towards Armstrong´s space adventure known as the Apollo 
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Program. In this part of the text the main focus was put on the difficulties that occurred while 
landing and what actually happened after it. The next part of the text is focused on 
Armstrong´s life after his space adventure and how this event affected him and his personal 
life. The last part of the interview deals with Armstrong´s present life and his views on the 
development process of future space programs. 
Cohesion: Throughout the whole text the author is changing the course of the conversation 
very swiftly. Even though the main subject is the same throughout the whole text 
(Armstrong´s personal life and his space adventure), there are a lot of variations on the topic. 
As I already mentioned, the whole text is one single unit because there is no introduction part, 
body or the conclusion. But the reader could easily get lost while reading the text, because the 
author shifts from one aspect of his life towards another and then comes back to something 
mentioned before, which is quite confusing. The cohesion of the text would be a lot better if 
the course of the conversation did not change so often.  
Sentence patterns: This text is comprised of short and rather simple sentences. Since the 
audience is general population, there is no need to use complex structures. As it is already 
mentioned, this is an informal text which can be verified while examining sentence patterns. 
For example, the text is comprised of few verbless sentences (such as “'Wow, oh, boy.”, 
“Perfectly speechless.”). Since the conversation is sifting between past and present time, the 
author uses past and present tenses depending on the time reference of the current topic.  
Terminology of the subject: Besides Armstrong´s life, the topic of this interview is space 
travel and accordingly the terminology is based on space flight and space technology basics 
(for example, “the lunar module”, “command module”, “cockpit“, “capsule“, etc.). The text is 
filled with colloquial expressions such as  “folks”, “superstars”, “thumbs-up“, etc. The rest of 
the used vocabulary  is a mix of a jargon and standard English language.  
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While translating this text, I came across few difficulties. The first was how to translate the 
name of the newsmagazine “60 Minutes”. The problem is that this show is not aired in the 
country of the target language, so there is no official translation. It is possible to improvise 
and translate the name literally, but then another issue occurs. There is a newsmagazine with 
the same name in this area and if we translate the name, the reader could easily mistake those 
two shows. In order to avoid possible ambiguity, I decided to leave the original name in the 
translation. 
Another issue I stumbled upon was translation of the phrase “famously private“. Since there is 
no equivalent phrase in the target language, I decided to use the descriptive phrase instead 
(“poznat po tome da se nikada nije previše izlagao očima javnosti”). Even though this 
translation is not concise, I think that it is the best way to transfer the meaning of the original 
phrase.  
Since this is an informal text, it is filled with colloquial expressions which can be tricky to 
translate. For example, the term “thumbs-up” does not exist in the standard Croatian 
language. After a thorough research, I decided to use the literal translation (“podignuti palac”) 
because this is an informal text and even though this term does not exist in the standard 
Croatian language, its usage is not so unusual among young people who use jargon.  
 Another phrase which was problematic to translate is “to turn blue”. My first association 
about this term was Croatian phrase “pozeleniti od muke”. But this phrase is not appropriate 
because it does not fit into the original context. The translator´s role is to examine the 
surrounding context of the word because it can be helpful while translating. And this was the 
case with this term. After examining the surrounding context, I concluded that the best choice 
for translation would be “ostati bez daha” because in the next sentence the author wrote 
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“We're breathing again.”. Moreover, the phrase “to turn blue” could literally mean to turn 
blue due to the lack of air.  
The phrase “watchful eye” used in the last part of the interview is an interesting example of 
how some phrases are used in the same context in the source and the target language. 
Translation of this phrase is “pratiti budnim okom”. Even though this is an informal text and 
the usage of this phrase would be appropriate, I decided to use another phrase instead 
(“pozorno pratiti”) because the literal translation is not in accord with the rest of the sentence.  
On several occasions the author used the term “Oh boy” in the text. Since this phrase does not 
exist in the target language, I decided to improvise and use the Croatian equivalent of that 
term (“O čovječe”).  
The translation of this interview was not that difficult since the vocabulary of the text is quite 
simple, suitable for everyday conversation. The terminology of the text is rather 
understandable.  The dialogues are filled with phrases which are used mostly in everyday 











Even though the definition of translation is quite simple, there is an entire hidden 
background story behind that term. Translation is a demanding task that requires a lot of effort 
from the translator. Translator needs to be an expert in the source language, but in the target 
language as well. Translating is a complex process and it has a lot of steps. Prior to the 
translation, translator needs to analyse the original text in order to familiarise with 
terminology, the structure of the text, style, tone, level of formality, etc. If it is necessary, 
translator can study similar articles written in the target language. After that, he or she can 
start the translation. While translating, the translator needs to bear in mind the culture of the 
source language, the context in which the text is written and the audience to whom the text is 
written. If he or she misses to include one of these elements into their translation, the final 
result will not be representative. It is a time-consuming process which requires patience, great 
knowledge of various topics and wide range of vocabulary and proficiency when it comes to 
the source and target language. These are just some of the skills which every competent 
translator need to possess. Even though translating can be really demanding, the final result 
makes it all worth it. Translator becomes an author because the translated text is actually his 
or hers work of art. 
In this thesis I have translated three texts of different genres. While translating I came across a 
lot of various issues, doubts and uncertainties. I dealt with medicine terms, terminology 
connected with finances, insurances, space travel and technology and so forth. Since I was not 
familiar with a lot of these terms, it was necessary to make a thorough research in order to 
make my translation the best possible. Even though it was a time-consuming process, I 
benefited from it. I have gained advanced knowledge about various topics and expanded the 
vocabulary of the source language, but the target language as well.  
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To conclude, translation is an elaborative process which contributes to translators in so many 
ways. It empowers them to learn about various cultures, fields of science and numerous 
interesting topics. What is more, while translating translators inevitably expand the 
vocabulary of the source and the target language. It enables them to master grammar, spelling, 
semantics and so many more as well. Translation is a process which involves a lot of hard 
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